key: cord-0067795-1aele65u
authors: nan
title: Abstracts des Kongresses für Kinder- und Jugendmedizin 2021
date: 2021-09-22
journal: Monatsschr Kinderheilkd
DOI: 10.1007/s00112-021-01281-y
sha: d526f3d7fa797d95d4019e279c48d548ef427782
doc_id: 67795
cord_uid: 1aele65u

nan

The proposed paper-with live demonstration (if possible)-discusses the ways in which the MotionComposer ( MC), a digital device that turns movement into music, engages users with different abilities, so as to provide positive psychological and somatic effects. The author is the inventor of the MC, and founder of the company (MotionComposer GmbH). There are currently around 20 MC's in use in Germany. The MC stands out for its overriding focus on inclusion-it may be used by persons with severe multiple disabilities.

Beginning with user case studies, the paper will discuss a number of goals and related design principles that have been important in the development of the device, including a discussion of two conflicting strategies which must be reconciled: On the one hand, there is a need for clear causality. On the other hand, for such a device to remain interesting over time, there is a need for variation and improvisation. In other words, while there must be a clear relationship-body-sound-at the same time, the player's movement-generated music needs to sound good in order to stimulate further movement. A review of research concerning music as therapy is given, followed by a technical description of the hardware and software and finally a discussion of mapping issues pertaining to the different sound environments and interaction modes of the MC. The MotionComposer ( MC) uses video tracking techniques to track the movements of the users and feeds the movement-derived data to soundgenerating software so that the users' movements in front of the camera are converted into sound and music in real time. Beginning in 2010 with support from the Bauhaus University, the MC team has been seeking support for the claim that interactive digital movement-to-music technologies can play a role in affording dance and music engagement among highly diverse users, including those with severe physical or mental conditions. With a focus on therapeutic, healthcare and pedagogic contexts, the MC falls among a small but growing number of devices and applications developed over the last few decades, which [1] use novel sensor and music technology, [2] let all kinds of users play music, and [3] Diskussion: Am Ende der Ernährungsintervention ist die Menge an proinflammatorischer AA (n-6) in Phospholipiden der Niere erniedrigt, dieser Effekt ist nach "second hit" nicht mehr zu beobachten. Jedoch bleibt die Menge an DHA (n-3, anti-inflammatorisch, anti-hypertensive) längerfristig erhöht. Derzeit laufen weitere Untersuchungen der Lipidmediatoren (Effektoren). Zudem wird untersucht, ob sich eine protektive Wirkung auf den Verlauf der Glomerulonephritis nachweisen lässt.

Abstract-Nr.: 43787, PO 012 Die Genexpression von Schlüsselenzymen des Fettsäurestoffwechsels in der Leber ist bei weiblichen Ratten nach intrauteriner Wachstumsrestriktion mittelfristig verändert Einleitung: Durch pharmakoepidemiologische Forschung lassen sich auch dort Erkenntnisse gewinnen, wo klinische Studien schwierig durchzuführen sind, wie zum Beispiel bei Kindern, die nur in interventionelle klinische Studien einbezogen werden sollten, wenn dies zwingend notwendig ist [1] . Dies gilt auch für STW 5 (Iberogast), ein pflanzliches Arzneimittel mit klinisch belegter Wirksamkeit bei funktionellen Magen-Darm-Erkrankungen [2] . Es ist für die Anwendung bei Kindern ab drei Jahren zugelassen, und es liegen Daten zu insgesamt 44.488 Kindern aus nicht-interventionellen Studien vor [3] . Ziel: Um diese Evidenz zu erweitern, wurden Daten aus der PhytoVIS-Studie, der mit 20.870 Teilnehmern vermutlich weltweit größten pharmakoepidemiologischen Studie zu pflanzlichen Arzneimitteln [4] , ausgewertet. Methode: Die enthaltenen 2063 Datensätze zu Kindern und Jugendlichen unter 18 Jahren [5] wurden auf die Anwendung von STW 5 gescreent. Ergebnisse: Insgesamt wurden 77 Datensätze ausgewertet (60 % weiblich, 40 % männlich). Häufigster Anlass der Einnahme waren Dyspepsie ( FD)-assoziierte Symptome (90 %), gefolgt von gemischten FD/ IBS-Symptomen (6 %) und IBS-Symptomen (4 %). STW 5 wurde zur Behandlung akuter (91 %) oder chronischer Symptome (5 %) und zur Vorbeugung (1 %) angewendet. In den meisten Fällen trat die therapeutische Wirkung innerhalb von 60 min nach der Einnahme ein. Die wahrgenommene Wirkung der Therapie wurde bei 60 % der FD-Patienten als sehr gut, 30 % als moderat und 10 % als gering eingestuft. Die Empfehlung zur Einnahme von STW 5 kam zu etwa gleichen Teilen von Ärzten, Apothekern oder Freunden/Familie. 7 % der Patienten berichteten leichte Unverträglichkeiten ohne signifikante Beeinträchtigung und 93 % berichteten überhaupt keine unerwünschten Wirkungen. Schlussfolgerungen: Die Ergebnisse bestätigen den therapeutischen Nutzen und die Sicherheit von STW 5 bei dieser Patientenpopulation [3] . Die Daten basieren jedoch auf einer subjektiven Bewertung durch die Pa-tienten und nicht auf einer Diagnose durch einen behandelnden Arzt. Doch sind solche Patient Reported Outcomes von wachsender Bedeutung in der Medizin. Background: The ethanol content in medicines has raised questions about child safety [1] . This is especially true for liquid dosage forms in which the dosage can be well adapted to different age groups, and also applies to herbal medicinal products, some of which are therapeutic options in children.

Purpose: The aim of this study was to present data on the extent to which children ingest ethanol when using these herbal medicines and how this is related to the intake of ethanol common foods. Methods: A systematic literature search was conducted, to capture data on the exposure to ethanol by the use of medicines in children, starting from 2008, when a reliable review was conducted [1] , and a review was prepared.

Results: Overall, 1032 references were retrieved, only few contributing to the subject of this review. Among these was an evaluation of exposure data from 17 non-interventional studies with 10 herbal medicines containing 0.03-0.23 g/ethanol per single dose, which covered data in 50,316 children from 0-12 years on. These studies and, in addition, spontaneous reports from more than 3 million children taking such herbal medicines showed no evidence of ethanol-related side effects [2] . In a further study, total ethanol exposure in children by common foods was evaluated by measuring the ethanol content in representative food items by gas chromatographic analysis and estimating exposure values [3] . It was shown, that orange juice, apple juice and grape juice contained significant amounts of ethanol (up to 0.77 g/l). Also certain packaged baked goods contained more than 1.2 g ethanol/100 g [3] . An extrapolation for mean ethanol intake in a 6-year-old child derived from these data revealed an ethanol exposure of up to 12.5-23.3 mg/kg. This amount is almost 2 times (average) or up to 4 times (high) higher than the exposure to herbal medicines (6 mg/kg BW), which is eliminated within 1-3 min [1] , and for which warnings for use in children is prescribed. Conclusion: In summary, our data suggest that in common foods consumed by pre-schoolers contain low, but measurable amounts of ethanol. The intake of ethanol with herbal medicines in these children is in an order of magnitude comparable to the daily exposure to foods, or even lower. Therefore, there is no specific risk associated with the ethanol content in herbal medicines. It therefore has no relevant impact on the benefit-risk assessment of these medicines in children. Hintergrund: Autoimmunhämolytische Anämien ( AIHA) sind selten und werden durch IgG und/oder IgM Antikörper ausgelöst, die zu einer Destruktion der Erythrozyten führen [1] . Ursächlich können Infektionen (z. B. Mycoplasmen, EBV, CMV), Autoimmunerkrankungen (z. B. SLE) oder primäre Immundefekte (z. B. ALPS) nachgewiesen werden [2] . Es können auch bedrohliche Verläufe vorkommen. Zur Behandlung werden Transfusionen und immunsuppressive Therapeutika (z. B. Prednison, Rituximab, MMF) eingesetzt [3] . [4] . Die Konzentration der Kälte-Auto-AK kann so hoch sein, dass eine Hb-Messung selbst bei vorsichtiger Erwärmung der Probe sehr eingeschränkt bis gar nicht möglich ist. Nach IVIG können die bei dem Patienten zusätzlich gemessenen EBNA Ak durch das Immunglobulin-Präparat bedingt sein [5] . Eine EBV induzierte AIHA konnte in diesem Fall ohne eine zusätzliche Immunsuppression erfolgreich behandelt werden.

Die Differentialdiagnose eines soliden Bauchtumors im Kindesalters ist breit: Neuroblastome, Weichteilsarkome, Nephroblastome und Hepatoblastome sind die häufigsten diagnostizierten abdominellen Tumore im Kindesalter [1] . Wir präsentieren hier den sporadischen Fall eines abdominellen Desmoidtyp-Fibromatose-Tumors. Desmoidtyp-Fibromatose-Tumore sind mit einer Inzidenz von ca. 5/1.000.000 und einem medianen Erkrankungsalter zwischen 30 und 40 Jahren eine sehr seltene Entität im Kindesalter. 5-10 % der Fälle entstehen im Kontext einer APC-Gen-Mutation im Rahmen einer familiären adenomatösen Polyposis ( FAP). Die übrigen, spontanen Erkrankungen weisen wie in unserem Fall Mutationen im CTNNB1-Gen auf. Der vierjährige Junge zeigte seit mehreren Wochen ein zunehmend ausladendes Abdomen ohne begleitende Schmerzen, Übelkeit/Erbrechen oder Durchfälle. Die Eltern sind asiatischer Ethnie, nicht konsanguin und es gibt eine neunjährige, gesunde Schwester. Tumorerkrankungen sind in der Familie bislang nicht aufgetreten. Bei deutlich vorgewölbtem Abdomen ist eine raumfordernde Masse druckdolent und derb über das gesamte Abdomen zu palpieren. Die Laborwerte sind weitestgehend unauffällig, sonographisch wird die abdominelle Masse zunächst als bis ins kleine Becken reichende Hepatomegalie gewertet. Mittels MRT wird eine maximal 18 × 20 cm große, abgekapselte und verdrängend wachsende Raumforderung dargestellt. Erst intraoperativ kann die Basis im Bereich der ventrolateralen Bauchwand rechts unterhalb des Rippenbogens festgestellt werden. Das Tumorgewicht von 2012 g macht ca. 12 % des Gesamtkörpergewichts aus. Histopathologisch wird ein Desmoidtyp-Fibromatose-Tumor und mittels Sanger-Sequenzierung eine passende CTNNB1-Mutation diagnostiziert. Initial eine operative Resektion statt einer Biopsie anzustreben sahen wir in diesem individuellen Fall durch Tumorgröße und klinische Symptomatik als indiziert an. Ohne diese und wäre schon präoperativ ein Desmoidtyp-Fibromatose-Tumor in differentialdiagnostische Erwägung gezogen worden, hätte statt einer Resektion leitliniengerecht eine Biopsie mit anschließender bildgebender watch-and-wait-Strategie erfolgen müssen [2] . Wegen diffuser Infiltrationen in die quergestreifte Muskulatur wurde histopathologisch ein R1-Stadium festgelegt. Es sind bildgebende MRT-Kontrollen gemäß der Consensus-Empfehlungen vorgesehen und bei Progress der Erkrankung ist der Start einer systemischen Therapie, in diesem Alter mit Methotrexat/Vinblastin geplant [3] . Die Gabe von Tyrosinkinase-oder γ-Sekretase-Inhibitoren scheint bei Erwachsenen erfolgreich, im Kindesalter fehlen bisher entsprechende Daten dazu [4] . Insbesondere Langzeittoxizität-Daten müssen für diese Therapie bei Kindern noch erhoben werden [5] . Introduction: Neurofibromatosis type 1 (NF1) is a multisystem pleiotropic genetic condition manifesting in childhood. The condition causes significantly increased malignancy risk contributing to both morbidity and mortality. Regular tumor surveillance is recommended. Various syndromes with different clinical course and subsequently management phenotypically overlap with NF1 recommending molecular confirmation in children suspicious of NF1. A misdiagnosis may lead to both insufficient (e. g. CMMRD) and/or unnecessary (e. g. Legius syndrome) cancer surveillance. Methods: We evaluate the clinical phenotype of children and adolescents fulfilling the diagnostic NIH criteria of NF1 of the University Children's Hospital Augsburg in a retrospective (chart review) and prospective manner.

If not done, diagnosis will be genetically determined. Aims: (1) To characterize the spectrum of clinical phenotypes of children with NF1; (2) To perform genotype-phenotype correlation for those genetically diagnosed; (3) To develop personalized surveillance. Results: To date, we have identified 70 children with suspicion/clinical diagnosis of NF1. Of those, 22 patients were reviewed in detail as of May 20th, 2021. The median age at this analysis was 9.8 years (range, 2. 1-19.4) . In 17 patients, clinical criteria of NF1 were fulfilled at the time of last follow-up. In 5 patients, there was an established family history. In 18 patients, diagnosis was confirmed by genetic testing revealing among others stop mutations, splice variants, (in-frame) deletions, microdeletions, and duplications. A total of 13 patients presented with any form of developmental disorder, ten patients with neurological symptoms, two with cardiovascular disease, and three with orthopedic manifestations including one patient with pseudarthrosis. In one patient, juvenile xanthogranuloma was diagnosed. Two patients were diagnosed with glaucoma. One patient was diagnosed with Moya-Moya at the age of 12 years. A total of 7 (10.0 %) patients were diagnosed with low-grade gliomas at a median age of 4.6 years (range, 2.8-7.9) necessitating surgery and chemotherapy, respectively. One patient was diagnosed with a malignant peripheral nerve sheath tumor at the age of 11 years. At last follow-up, no patient had died. Background: Implantation of ventriculoperitoneal ( VP) shunts is a standard therapy of hydrocephalus. After the operation infection and mechanical failures are the most frequent complications. Thoracic complications like pleural effusion or intrathoracic migration of the VP shunt have been rarely reported. Case report: We report on a girl with primary global developmental disorder. At the age of 10 months the girl had a septic shock with cardiopulmonary arrest in the context of severe pneumonia with Influenza A. Following a meningitis 3 months later she developed a postinfectious hydrocephalus occlusus requiring placement of a VP shunt. At the age of 4 years she was hospitalized with 3 weeks persistent clinical signs of pneumonia. C-reactive protein was increased (19,8 mg/dl) and serology was positive for mycoplasma pneumoniae. We started calculated antibiotic therapy with Piperacillin/Tazobactam and Clarithromycin. Microbacterial and virological findings were negative in all body fluids. Echocardiography showed a 10 mm secundum ASD with left-right shunting and tricuspid regurgitation grade II while sonography revealed a huge right sided pleural effusion. Because of progressive respiratory deterioration we decided to drain the pleural effusion by a chest tube. The clear serous fluid of the effusion showed laboratory criteria of a transudate and was interpreted as a complication of the pneumonia. We noticed continuing high drainage rates up to 1400 ml in 24 h. Radiologically, VP shunt showed a regular intraperitoneal position. Beta trace, as sign of a leakage of cerebrospinal fluid, could be detected in the pleural drainage secretion (2,7 mg/l) but the replacement of the shunt valve and shortening of the abdominal catheter resulted in no improvement. Single Photon Emission Tomography combined with low-dose computed tomography revealed transition of fluid from intraperitoneal to the right pleural space comfirming an abdomino-thoracic communication. As a next step we performed neurosurgical externalisation of the VP shunt which resulted in complete cessation of the right pleural effusion. VP shunt was explanted, an external liquor drainage was placed and a plexus coagulation was performed to reduce cerebrospinal fluid production. No relevant cerebrospinal fluid cushion developed after the removal of the external liquor drainage. In the follow-up no increased head circumference or neurological symptoms could be detected, so that no further shunt system was necessary. Conclusion: Abdomino-thoracic liquor fistulas in patients with VP-shunts have been described in several case reports and must be ruled out if pleu-ral effusion are detected. Based on a gap in the diaphragm, which acts as a valve, large amounts of fluid may be suctioned to the pleural space. This one-way flow is probably due to a pressure gradient resulting from negative intrathoracic and positive abdominal pressure during the inspiration. Here, we present two recent cases of SUDI in full buckle baby carriers, to our knowledge the first cases reported in Germany. Case reports: Both infants were healthy, full term babies at the age of 1 month and 2½ months, respectively. They were carried in full buckle baby carriers by one of the parents, presumably asleep, when a cease of spontaneous breathing and cardiac arrest was realized. Both infants presented bloody nasal or mouth discharge. Medical emergency teams were successful in establishing return of spontaneous circulation after 45 and 50 min, respectively. Laboratory examination at hospital admission indicated multi-organ failure. Neurological investigations revealed loss of brain function and MRI scans showed signs of hypoxic-ischemic encephalopathy in both infants. There were no signs of child abuse in guideline-based examinations. A multidisciplinary panel recommended to withdraw life support, in mutual consent with the parents, considering the absence of spontaneous breathing. Discussion: Patients' histories, clinical and apparative findings combined with post mortem examinations strongly suggest suffocation as mechanism of death and lead to the overall conclusion on SUDI. Reviewing previous case reports, the circumstances leading to suffocation in adult-worn full-or half buckle baby carriers and baby slings are similar. Airway obstruction and suffocation presumably occur when the infant falls into a chin-to-chest position. Furthermore, when the infant is fully contained by the baby carrier or baby sling, it may be forced into a C-shaped, curved positioning of the spine, which may aggravate airway obstruction. In addition, the infant's nose or mouth might be obstructed by the adult's body or the device itself, especially when the size of the carrying device is inadequate. Conclusion: Despite their growing popularity, baby slings and baby carriers may exhibit a significant risk for SUDI. These devices should be used with particular caution in infants below 4 months of age, until neurodevelopment allows complete head control. According to the age and weight of the infant, parents should focus on correct size and fitting of the strapon device. Appropriate warnings and instructions need to be provided by manufacturers and health professionals, e. g. at the well-baby examinations scheduled for 3-10 days (U2) and 4-6 weeks (U3). Background: Myocardial deformation can be quantified using strain and strain rate, functional parameters that are proving to be of diagnostic and prognostic value in various cardiac diseases. A technique to assess myocardial strain on routinely acquired cardiovascular magnetic resonance ( CMR) sequences is feature tracking. Although reference values are essential for the implementation of strain imaging in clinical practice, detailed data in the paediatric age group is limited. The aim of this study was therefore to provide reference values for strain and strain rate of all four chambers of the heart. Methods: Feature tracking measurements were performed using CMR cine steady state free precession images of 163 healthy children (age 0.5-18 years). Left ventricular global and regional longitudinal, circumferential and radial strain and strain rate as well as right ventricular and atrial global and regional longitudinal strain and strain rate were measured on 2-, 3-and 4-chamber views and the short axis stack. The influence of demographic factors on global strain was analysed and percentile curves and tables were created using the lambda-mu-sigma ( LMS) method of Cole and Green. In a large retrospective study in Great Britain, NHS data of all inpatient admissions between January 2000 and March 2013 were used. The presence of IE-predisposing heart disease was determined by means of ICD-10 discharge diagnoses and OPCS-4 procedure codes. A logistic regression analysis was used to calculate the relative risk of the different patient groups, classified according to the risk groups of the IE guidelines of the ESC and the AHA, of developing or dying from IE over the next 5 years. The IE-related inpatient admissions or deaths of the entire English population during the same period were used as a reference value. The incidence of IE in the English population was 36 cases/1 million inhabitants/year, the mortality rate in the context of IE-related hospitalization was 6.3/1 million inhabitants/year (17 %). The incidence of IE was highest in patients with previous IE (266 × higher than the reference group) and after valve replacement (70 x) or valve reconstruction (77 x). It was also high in patients with congenital heart defects who had been treated with a shunt/conduit (86 x). The incidences for subgroups with a previously unclear risk were very differentvery high for patients with an artificial heart/left ventricular assist device ( LVAD, 124 x), significantly lower for patients with an implanted pacemaker/cardioverter-defibrillator (10 x) and for heart transplant recipients (6 x). Conclusion: For the first time, the study provides a valid risk comparison and thus important new aspects that should be taken into account in future IE prophylaxis recommendations. In everyday clinical practice, the initial suspicion of IE in the identified high-risk groups should be correspondingly high; adequate diagnostic work-up essential. We present 2 cases of infants admitted with febrile COVID 19 infection and developing atypical haemolytic uremic syndrome (aHUS) during the first week of hospitalization. AHUS is a rare disease due to uncontrolled activation of the complement system and characterized by systemic thrombotic microangiopathy ( TMA), mainly in the kidneys, leading to acute renal failure.

There is increasing evidence that COVID-19 is associated with microvascular injury. Furthermore complement activation plays a role in the pathogenesis of severe COVID-19-disiease. First case: A 4-month-old boy, ex-premature of 26 weeks, was admitted with a febrile COVID-19 infection. On day 5 typical signs of HUS developed (anaemia, thrombocytopenia, high LDH and progressive kidney failure) and the boy was admitted to the PICU on day 8 for Tenckhoff-catheter implantation, peritoneal dialysis and management of Hypertension. Due to high suspicion of aHUS, eculizumab was given on day 8. With this treatment he improved constantly and peritoneal dialysis could be stopped after 4 weeks. Thrombotic thrombocytopenic Purpura ( TTP) was excluded by normal ADAMTS-13 values.

The boy was discharged after 6 weeks with remaining serious arterial hypertension. Second Case: A 4,5-month-old boy was admitted with fever, diarrhea and reduced drinking for 3 days. SARS-CoV-2 PCR testing was positive, initial blood cell count, infection signs, lumbar punction and chest x-ray were unremarkable, blood gas showed mild dehydration. Kidney ultrasound was normal on admission. Initially he received fluid resuscitation and antipyretic treatment. On day 4, he developed anaemia, thrombocytopenia, rising LDH, schistocytes and echogenic kidneys. Given the clinical suspicion of atypical HUS we immediately treated with Eculizumab. Despite this treatment the child developed acute kidney failure with anuria, severe arterial hypertension, requiring PICU admission and peritoneal dialysis on day 8. Initially arterial hypertension was refractory to triple IV-continuous treatment. However, during dialysis de-escalation was slowly possible. As for case 1, TTP was ruled out by normal ADAMTS-13 values. Stool screening was unremarkable. Further Complement functional studies and genetic screening are ongoing. Discussion: It is well known that aHUS can be triggered by infectious disease, so that in our two cases the Covid-19-infection might just have served as a trigger, but in general aHUS is a rare disease, so two similar cases within a month is very unexpected. There is growing evidence that severe Covid 19 disease is linked to disproportionate complement activation leading to thrombotic complications and poor outcome. Therefore, the development of a complement-mediated thrombotic microangiopathy in our two cases might be the result of a severe Covid-19 infection with overactivated complement system directly due to the Covid virus and not necessarily due to an underlying genetic complement disorder. Purpose: Febrile infection-related epilepsy syndrome ( FIRES) is a rare epileptic encephalopathy, characterized by acute onset of refractory status epilepticus ( SE) of unknown cause. As FIRES begins with febrile illness, autoimmune encephalitis ( AE) is usually suspected after infectious encephalitis was ruled out. Up to now, AE has not been verified in FIRES.

We searched for known and unknown antineuronal antibodies in serum and cerebral spinal fluid ( CSF) obtained during SE in children with suspected FIRES. Inclusion criteria were as follows: new onset of refractory SE following a non-specific febrile illness in the preceding two weeks, without pre-existing epilepsy, and without clear acute cause, e. g. infectious encephalitis. A tissue-based immunohistochemistry ( IHC) assay using rat brain was performed to screen for antibodies directed against the neuropil in serum and CSF. Positive tested samples were examined for known antineuronal antibodies using indirect immunofluorescence (antibodies against NMDA-R, IGLON5, CASPR2, GABAB-R, mGluR5, DPPX, AMPA-R, LgI1R), as well as radioimmunoassay ( VGKC). Subsequently surface-localized antibodies on primary culture neurons were examined by primary neuron culture staining. We retrospectively evaluated demographic and clinical data. This study was approved by the ethics committee of the Kiel University. Results: Serum and CSF from 14 consecutive children (4 females, 10 males) with a median age of 6 years (range 4-9 years) at onset of suspected FIRES were examined. Ten children (8 males, 2 females) had no more fever at onset of SE. Duration of SE ranged from few days to 2,5 months (median 4 weeks). Reported outcomes were poor in all children (significant neurological disability and chronic epilepsy). CSF (obtained on first or second day of SE) white blood cells ( WBC) ranged from 0-178 cells/µl (median 7 cells/µl) and protein levels ranged from 13.2-648 mg/dl (median 35.1 mg/dl). We found antineuronal antibodies in only one child. This 6-year-old boy had antibodies targeting hippocampal neuropil in CSF but no antibodies in serum. The antibodies detected hippocampal neuronal surfaces but none of the known autoantigens. Therefore, it was considered an unknown antineuronal antibody. In contrast to the other children in this study, the boy with the anti-neuropil antibody with unknown antigenic target presented with seizures already at the first day of fever. Additionally, initial CSF findings were normal but, on the following day, second lumbar puncture revealed elevated WBC (178 cells/µl) and elevated protein level (648 mg/dl) with intrathecal IgM-synthesis. SE, however, failed to respond to corticosteroids as in all but one of the other children. Conclusion: FIRES seems to be a mostly antibody-negative encephalopathy. AE, however, remains an important differential diagnosis of FIRES because AE is potentially treatable with immunotherapy. The effect of vosoritide administration on growth as measured through AGV and height Z-score was maintained for up to 2-years in children with achondroplasia aged 5-18 years, with an improvement of body proportions.

Background: Germline mutations affecting the genes SMARCB1 or SMAR-CA4 are associated with an increased risk for the development of malignancies i. e. rhabdoid tumors ( RT) (rare and highly aggressive malignant tumors occurring predominantly in infants and children younger than 3 years). They may also predispose for tumors other than RT (e. g. schwannomas CRINET, SCCOHT Introduction: Long-chain fatty acid oxidation disorders ( LC-FAOD) are rare autosomal recessive defects in genes encoding mitochondrial enzymes that convert long-chain fatty acids into energy. LC-FAOD can cause unpredictable, life-threatening episodes of rhabdomyolysis, hypoglycemia, and cardiomyopathy. Triheptanoin is an odd-carbon, medium-chain triglyceride indicated as a source of calories and fatty acids for the treatment of patients with molecularly confirmed LC-FAOD. The LC-FAOD DMP is an alternative to traditional registries that will consistently monitor disease manifestations and effects of treatments over a 10-year timeframe. Methods: The LC-FAOD DMP consists of two distinct, long-term (10-year), prospective observational studies planned to provide data on the natural history of the disease, as well as effectiveness and safety of treatments from different perspectives: clinical visits in study CL401 and at home data collection in study CL402. No treatments or interventions will be provided by the Sponsor for either study.

Results: The in clinic study (N = 300) will collect data during clinic or telephone visits by site staff. Patients will have in-clinic visits at Enrollment Baseline, Month 6, Year 1, and Year 2, with alternating annual telephone and in-clinic visits starting at Year 3.

The online study (unlimited number of participants with LC-FAOD) will collect self reported, real time data using a mobile/web-based application accessed by patients or caregivers.

The LC-FAOD DMP will provide comprehensive clinical and online data for 10-years. A unique, core tenet of the CL402 DMP is the planned sharing of data with the participants that will include both personalized data and de identified/aggregated data from all participants. To develop and pilot a pedACP framework employing a participatory approach to meet the needs of children, parents and professional stakeholders.

The pedACP development process encompassed two transdisciplinary workshops with bereaved parents and stakeholders. In a first workshop, four key elements of the pedACP process were identified. In a second workshop, parents and professionals worked collaboratively in three mixed groups to organize the key elements in a timeline. These results were analyzed, systematized and translated into a pedACP program, which was revised by the participants. The ongoing pilot study evaluates the feasibility and effects of the program.

The overarching focus of the participants was the children's quality of life and the necessity of an individualized iterative conversation process along the disease trajectory. Therefore, the pedACP program was conceptualized using a modular design. The purpose of the fixed modules at the beginning is building a trustful relationsship and framing the process. The main conversations are structured in four flexible modules: About the child, Emergencies, Disease-specific scenarios, End-of-life care. At the end, two modules aim at ensuring validation of written ACP documents and implementation in the individual care network. The program includes a guide for professionals and information materials for parents. The participants valued the flexibility and comprehensiveness of the program. First results of the ongoing pilot phase will be presented.

The pedACP program MAPPS was developed in a participatory process to include parental und professional expertise. Key elements of pedACP were identified and translated into a modular framework, which focuses on an individualized approach for each child and family and takes the needs of health care professionals into account. Abstract: Abdominal wall defects such as omphalocele or gastrochisis are well recognized entities for pediatric surgeons. Mild forms of omphalocele can present as congenital hernia of the umbilical cord. We report a case of a 2 days-old neonate with an ileal perforation due to clamping of an exomphalos minor. This complication presents the failure to diagnose the exomphalos minor without explicite inspection and to clamping of the umbilical cord too close to the abdominal wall. Case description: A 2 day old girl was referred from an external hospital with a 4 h history of bilious, stool-like vomiting and abdominal distension. The infant had been born at term by spontaneous vaginal delivery and weighed 3400 g. The pregnancy had been unremarkable with no history of polyhydramnios; all prenatal ultrasound scans had been normal. After birth the newborn had good condition. Routine care was done to the patient and a broad based umbilicus cord was clamped by a midwife about 2 centimetres from the umbilical base. He was started on breast milk feeds and had passed meconium. 12 h after birth a bluish-livid swelling appeared distal to the umbilical clamp and the baby started to vomit milk with transition to bilious stool-like vomiting. A nasogastric tube was passed and the patient was transferred to out department of pediatric surgery. At the first physical examination the patient showed a stable general condition with rosy skin color, regular skin turgor and prompt recapillarization. Heart and lungs were unremarkable on auscultation, pulses were well palpable axillary and inguinal. The abdomen was distended and tender to palpation with absent bowel sounds. The umbilical cord remnant distal to the umbilical clamp appeared bluish-necrotic swollen, with the size of approximately of 1.5 × 1.5 cm and covered by wharton's jelly The anus was regularly apposed. A large amount of meconium was discharged during the examination. The external genitalia was inconspicuous. Labatory findings showed elevated CrP and PCT. Ultrasound showed umbilical vessels and intestinal loops lying in the direction to the umbilical clamp. IV fluids and antibiotics were initiated and the patient was prepared for urgent laparotomy. Intraoperatively, a loop of intestine herniated through the umbilicus was found to be pinched off by the applied umbilical clamp and thus necrotically altered. Resection of the necrotic bowel segment and primary end-to-end anastomosis of the bowel was performed. The infant made an uneventful recovery and was discharged home for review in outpatient clinic. Patient perspective: Careful inspection of the umbilical cord of every newborn before clamping is essential. Obstetricians, paediatricians and nurses who clamp the cord (at least 5 cm from the abdominal wall) should be cognizant of an abdominal wall defect with herniation of interstine into the cord. Moreover we emphasise that in minor forms of exomphalos the diagnosis is not always immediately obvious.

Introduction: Colonic duplication may present in different anatomic variants. The surgical approach towards these anomalies can be challenging and has implications for subsequent future continence. Case description: We report on a 1-year-old girl with congenital heart defect who was referred with an anorectal malformation. The patient was stooling from both perineal fistula and anus. Examination under anaesthesia revealed an orthotopic and age-appropriate sized anus with surrounding sphincter and a second rectal lumen ending as a perineal fistula. A CT and barium enema indicated colonic duplication. Exploratory laparotomy showed a duplicated terminal ileum leading to two caeca and appendices, which joined to a duplicated colon with a septum and common mesentery. At the recto-sigmoid junction, one part of the duplication was ending as a perineal fistula, the second one led to the (orthotope) anus. The common colonic wall was divided using a stapler. The rectal duplication leading to the perineal fistula was not resected but treated by mucosectomy only (Soave plane) leaving its muscular cuff in place. Finally, an ileostomy was created. The postoperative course was uneventful. A barium enema prior to ostomy takedown demonstrated a well-configurated colon and rectum without stenosis or impaction. In the follow-up, the girl was continent with a complete resolution of her constipation. Conclusion: In cases of complete colonic duplication division of the common wall is simple and safe. Mucosectomy of the ectopic rectum limits pelvic dissection and preserves the entire muscular wall of the duplicated orthotope rectum. Congenital mature teratomas of the umbilical cord are extremely rare. We report on a girl who presented with a ruptured omphalocele and a 7 cm mass connected to the umbilicus, which we resected on the first day of life. Histology revealed mature umbilical cord teratoma ( UCT). On the 29th day of life, a secondary laparotomy was necessary to address the associated intestinal malformations (megaduodenum, stenotic small bowel with duplication and malrotation). After a prolonged hospital stay, we discharged the patient in age-appropriate conditions. Antenatal diagnosis of an umbilical cord tumor can be challenging in the presence of an omphalocele. Given the high prevalence of associated malformations, the finding of umbilical cord teratoma should be followed by a detailed and comprehensive neonatal workup for additional abnormalities. Introduction: Sigmoid volvulus in the neonate is an extremely rare lifethreatening condition needing emergency treatment. Sigmoid volvulus has been described only twice in the literature in association with anorectal malformation ( ARM). However, newborns with ARM might be especially at risk for sigmoid volvulus due to bowel obstruction. Clinical signs of sigmoid volvulus are non-specific, but the pathognomonic "coffee bean" sign on abdominal X-ray enables this vital diagnosis to be easily made. Case report: A 7-month-old boy initially presented to our hospital for an ARM follow-up visit. His medical history reported an ARM without fistula and unexplained sigmoid perforation on his fifth day of life. We performed a thorough review of the medical history. The boy was born at 37 weeks of gestation. An ARM was visually diagnosed postpartum. An abdominal X-ray was taken at five hours of life to confirm correct placement of an umbilical venous catheter; two air bubbles were noted. The patient was transferred on the second day of life to a "high-volume center" for anorectal surgery in the newborn. Abdominal X-ray was repeated at 27 h of life, with the radiologist's evaluation being: "… A dilated intestinal sling of up to 3,2 cm of diameter reminds of the "coffee bean" sign as seen in sigmoid volvulus and is most likely originated in the sigmoid …" At 29 h of life a transverse colostomy was placed in the right upper quadrant using minilaparotomy. The intraoperative finding was of a severely distended sigmoid colon in the right upper quadrant, with no signs of gangrene. No further measures were taken to treat or follow up the sigmoid volvulus.

On the fourth postoperative day the general condition of the patient deteriorated and the abdomen distended. The intraoperative findings of an emergency laparotomy on the following day were of a generalized meconium peritonitis; an approximate 5 mm perforation was detected at the distal sigmoid. The perforation was sutured, and a simultaneous PSARP was undertaken. The patient went into septic shock with multiorgan failure. No recurrence of sigmoid volvulus had occurred at 12 months of life. Discussion: Clinically the presentation of sigmoid volvulus cannot be distinguished from the presentation of a distended abdomen that is due to ARM, and yet X-ray of the abdomen is not a routine preoperative diagnostic. The decision between either performing a primary PSARP or the placing of a colostomy is based on clinical evaluation and abdominal ultrasound alone. In the case of our patient, initial X-ray was performed only because an umbilical venous catheter had been placed. Intraoperatively, the surgeon did not consider sigmoid volvulus despite the preoperative Xray. This case history demonstrates the urgent need to raise awareness to the existence of sigmoid volvulus in the neonate with ARM.

Background: Given the absence of consolidated and standardized international guidelines for managing pediatric appendicitis and the few strictly data-driven studies in this specific, we investigated the use of machine learning ( ML) classifiers for predicting the diagnosis, management and severity of appendicitis in children. Introduction: Since the number of clinical studies in children is limited, pharmaco-epidemiological research can be an important source of information on pharmacotherapy. To gain insight into the use of herbal medicinal products in this age group, data from the PhytoVIS study, presumably the world's largest pharmacoepidemiological study on the use of herbal medicinal products [1] , were evaluated focusing on the paediatric population.

The PhytoVIS data set has been captured in doctor's practices and pharmacies in compliance to the ENCePP Code of Conduct [2] . It was screened for data on indications, treatments, perceived effect and tolerability in the paediatric population [3] . Results: Overall, 2063 data sets from paediatric patients were evaluated, thereof 254 from patients below 2 years, 473 from patients age 2-5 years, 551 from age 6-11 years and 785 from age 12-17 years. The majority of patients (67.7 %) was treated because of common cold and fever, other reasons for herbal therapy were gastrointestinal disorders, injuries and pain among others. A co-medication was documented in 24.9 % of patients. The efficacy of the therapy was rated very good in 48.4 % of patients, good to moderate in 36.8 %, missing in 4.0 %. Out of all patients 93.7 % experienced no adverse events at all, only 0.8 % felt a marked impairment due to side effects. Neither the efficacy nor the tolerability seemed to differ depending on the age group evaluated. Discussion and conclusion: These results shed light to a field of pharmacotherapy for which data were rare and give a picture of the use of herbal medicines in an unselected cohort of paediatric patients. They clearly show the safety and therapeutic usefulness of phytopharmacotherapy in children. By this, they also provide good background information for therapeutic decisions based on the overall tolerability and perceived effect. Funding: The study is supported by Kooperation Phytopharmaka GbR, Bonn, Germany. Fallbericht: Ein 2-jähriger Junge mit Fieber über 3 Tage und Gehverweigerung zeigte eine schmerzhafte Arthritis in Ellenbogen-und Kniegelenken beidseits mit Morgensteifigkeit und nächtlichen Schmerzen. Im Verlauf kam es zu 8 Fieberepisoden dieser Art in 4 Monaten, z. T. begleitet von Arthritiden die jedoch spontan rückläufig waren. Ungewöhnlich waren anhaltende motorische Rückschritte beim Gehen: er zeigte einen neu aufgetretenen, unsicheren, breitbasigen Gang. Die Entzündungszeichen im Fieber waren nur gering erhöht ( CRP 3 mg/dl, BSG 30 mm/h), die Serologien für reaktive Arthritiden waren negativ. Bei der Diagnostik zeigte sich im Ganzkörper-MRT eine Gonarthritis und Enthesitiszeichen (am Trochanter major bds). Eine Knochenmarkpunktion war unauffällig. Es fanden sich keine Auffälligkeiten im EEG, NLG, Schädel MRT und CT und Liquor. Nachdem molekulargenetisch ein familiäres Mittelmeerfieber ausgeschlossen war, veranlassten wir ein (Trio) whole exom screening. Dies zeigte einen heterozygoten Nachweis der pathogenen de novo-Variante Arg-822Gln im IFIH1-Gen. Es zeigte sich eine mäßig-bis mittelgradig erhöhte Expression Typ 1 Interferon-induzierter Gene im peripheren Blut. Diskussion: Verschiedene Varianten im IFIH1 Gen sind als Ursache des Aicardi-Goutières-Syndroms ( AGS) Typ 7 beschrieben worden (1). Das Aicardi-Goutières-Syndrom gehört zu den Interferonopathien und geht meist mit einer ausgeprägten neurologischen Symptomatik einher. Bei der hier vorliegenden Arg822Gln Variante im IFIH1-Gen wurden jedoch andere Krankheitszeichen beschrieben: aortale Kalzifikationen, Zahnabnormalitäten und Osteopenie. Diese Konstellation wurde als Singleton-Merton-Syndrom benannt (2) . Die genannten Zeichen liegen bei unserem Patienten nicht vor. Eine phänotypische Variabilität, u. a. mit systemischen Lupus erythematodes-ähnlichen Manifestationen wurde zudem beschrieben (3) . Unser Patient zeigt motorische Rückschritte, die eher zum "klassischen" Aicardi-Goutières-Syndrom passen, sowie die Fieberepisoden und schmerzhafte Arthritiden, die bisher bei den IFIH1 Mutationen nicht beschrieben sind. Introduction: The recognition of adenosine deaminase-2-(ADA2)-deficiency (DADA2), a monogenic vasculitis syndrome, is important due to the significant morbidity associated with the increased risk of stroke and vasculopathy.

Objectives: DADA2 has a highly variable clinical presentation including signs of vasculopathy (e. g. livedo reticularis, vasculitis, stroke), systemic inflammation and musculoskeletal findings e. g. arthritis and myositis, which is not widely recognised to be a typical finding associated with the diagnosis. Methods: We report the diagnostic work-up and management of two patients with DADA2, where myositis was a key symptom to reaching the diagnosis. Results: Patient 1 and 2 (both female, Turkish-German ethnicity), presented aged 5 and 10 years respectively, with muscle and joint pain, a history of fever attacks and livedo reticularis beginning in infancy. Inflammatory markers including serum amyloid A, were persistently elevated in both patients. Diagnostic tests ruled out HIDS, Blau Syndrom (Patient 1), as well as Bechet's Disease (negative HLA-B51 and Pathergie test), CAPS, TRAPS and FMF. However, Patient 2 was positive for the non-pathogenic FMF heterozygous mutation A744S. Initial therapy for both patients was colchicine with varying compliance and effectiveness. In patient 1, therapy was extended to include azathioprine and due to minimal effect, oral cortisone. Unfortunately, both patients attended sporadically and were non-compliant with therapy. In this time, Patient 1 was found to be a distant relative of Patient 2. Ten years after initial presentation, Patient 1 complained of muscle pains in the thighs. CK was normal, PM-Scl antibodies were positive and whole-body MRI showed muscle oedema and inflammation particularly affecting the vastus medialis and gracilis muscles. In combination with a history of trochlear nerve paralysis, the diagnosis of DADA2 was suspected. Once confirmed with genetic testing, treatment was initiated with the TNF-Inhibitor adalimumab. Fever and inflammation episodes did not reoccur, and the muscle pain resolved. Patient 2 was invited for reevaluation after being lost to follow-up. However, before attending, she suffered a lacunar thalamus infarct. Genetic testing and etanercept were initiated after acute neurological management. The patient had first developed muscle pains in the upper and lower legs 2-3 weeks after the infarct, without elevated CK. Whole-body MRI confirmed myositis of the symptomatic muscles. Conclusion: In patients with recurrent autoinflammation and myositis and an otherwise unclear diagnosis, DADA2 should be considered as a possible cause. Whole-body MRI can help confirm myositis. A thorough family history and genetic testing are vital to reach the diagnosis. 

Systemic autoinflammatory diseases (SAIDs) are characterized by episodes of systemic inflammation, caused by dysregulation of the innate immune system. Mendelian-inherited pathogenic variants in distinct genes may account for these diseases in a significant proportion of patients, however, disease-causing variants may present with variable expressivity. Furthermore, pathogenic germline variants that may explain the disease phenotype cannot be detected in the majority of patients, particularly in those suffering from "complex" SAIDS, e. g. PFAPA-syndrome or chronic non-bacterial osteomyelitis ( CNO), as the most common SAIDs in children.

Interestingly, non-Mendelian inheritance of somatic variants has increasingly been described to account for or modify the clinical phenotype of SAIDs. A 13-year-old girl was presented to our pediatric department with a history of recurrent fever and oral ulcers and pain in the legs. Recurrent episodes with fever, aphthous stomatitis and pharyngitis, that responded well to corticosteroids, started at the age of 18 months and the diagnosis of PFAPA-syndrome was made. At the age of 5 years, the fever episodes suspended, while aphthous stomatitis continuously persisted since then. Additionally, the patient reported severe pain in the legs since the age of 11 years. Whole-Body MRI displayed multifocal lesions with bone edema and contrast-enhancement in the right proximal femur metaphysis, both tibial metaphyses as well as right talus/calcaneus compatible with CNO. Her differential blood count showed mild neutropenia (1300/µl) and macrocytosis ( MCV 101 fl). Vitamin B12-deficiency was ruled out. Bone marrow aspirates did not show significant dysplastic alterations. However, cytogenetic analysis revealed a 47, XX+8 karyotype in 68 % of the analyzed interphase nuclei. These genetic alterations remained unchanged in a 6-months follow-up analysis without significant signs of dysplastic alterations and could also be detected in 64 % of peripheral blood mononuclear cells suggesting either constitutional or acquired mosaicism. Whereas short-term treatment of corticosteroids alleviated skeletal pain, long-term treatment with colchicine had no impact on the oral ulcerations. Hence, TNF-α inhibition (adalimumab) was initiated and the patient is in clinical remission since then. Acquired Trisomy 8 is a common finding in myelodysplastic syndrome ( MDS) and in conjunction with MDS associated with inflammatory disorders, e. g. Behcet-spectrum like symptoms. Additionally, increased prevalence of periodic fevers and/or aphthous stomatitis has been reported in rare patients with constitutional trisomy 8 mosaicism. We herein present a patient with complex autoinflammatory symptoms most likely associated to an acquired or constitutional trismomy 8 mosaicism. Current experiments are ongoing to dissect the distribution of aneuploid cells within distinct cell lineages and correlate this to potential aberrant gene expression and function. Ergebnisse: Analysiert wurden 51 Patienten (♀ = 34; ø Alter: 10,9 ± 3,1 Jahre), deren Krankheitsaktivität mit dem cJADAS-10 auf 13 ± 5 eingeschätzt wurde. 10 von 50 Patienten (20 %) gaben an, in den letzten 7 Tagen vor dem Klinikaufenthalt mindestens 60 min am Tag körperlich aktiv zu sein ( WHO-Vorgabe) (ø 3,3 ± 2,5 Tage). 82 % trieben Sport und 62 % (n = 50) sind zu diesem Zeitpunkt aktives Sport-Vereinsmitglied. Die Hälfte der Patienten schätzt die eigene körperliche Leistungsfähigkeit als sehr gut bis gut ein (44 % mittel, 4 % nicht besonders, 2 % gar nicht gut; n = 50). Der Stellenwert von Sport in der Familie ist bei 72 % der Patienten sehr hoch bis eher hoch (28 % eher niedrig, 0 % gar keinen; n = 50). 35 von 50 Patienten (70 %) haben ein sehr großes bis großes Interesse an Sport (18 % mittel, 10 % gering, 2 % sehr gering). Spaß wird als häufigstes Motiv zum Sporttreiben genannt (96 %, n = 49). 82 % haben das Ziel sich mehr zu bewegen (n = 28) und 69 % möchten gezielter Sporttreiben (n = 32). Die Sorge, dass das Sporttreiben aktuell Schaden könnte, wurde auf der NRS-Skala (0-10) mit ø 3,2 ± 3,1 (n = 50) eingeschätzt. Introduction: Ultrasound B-Mode ( BM) and vascularity ( PD) can discriminate normal and pathological findings, identifying joint effusion, synovial proliferation and hypervascularity in patients with juvenile idiopathic arthritis ( JIA). Physiological ultrasound ( US) findings for the paediatric knee joint has been published in 2016 by the Imaging Working Groups of the GKJR and OMERACT. Objectives: To compare knee joints of JIA patients with and without arthritis using pD and bM to determine the most sensitive US views in an international multicenter study. Methods: Patients aged < 18 years attending with clinical symptoms of arthritis of 1 or both knee joints in 6 participating centres were recruited. Standardized US examination was performed (Table 1 ) using a linear transducer and bM and pD findings were graded 0 (normal)-3 (severe) according to the adapted OMERACT-US score. Sensitivity is expressed as frequency of Grade 1,2 or 3 (%). Results: A total of 75 individual knee joint examinations in 53 patients were performed, knees without arthritis were controls. Patient reported symptoms of arthritic knees were swelling (98 %), loss of function (85 %) and pain (83 %). At the time of scanning, 57 % of patients were using NSAR therapies, 23 % methotrexate, 2 % biological and 2 % oral steroids. In BM, the commonly used anterior longitudinal standard view performed in 30° remained the most sensitive for assessing effusion when used as independent view (95 %). However, PD in lateral parapatellar (69 %) and lateral longitudinal views (64 %) were more sensitive than the typically evaluated anterior longitudinal (44 %) and transverse (55 %) in neutral view. The highest sensitivity for hypervascularization was seen in the lateral and medial parapatellar views (69 % and 62 % respectively), the lateral longitudinal (64 %) and the anterior transverse and longitudinal views performed at 30° (63 % and 64 % respectively). Conclusion: These preliminary findings suggest US could be performed with knees in 30° flexion (anterior longitudinal and transverse) for maximal BM sensitivity. These views combined with the lateral parapatellar and longitudinal views as marker for hypervascularity provide the most sensitive US method. Stationäre Einweisung über unsere immunologische Sprechstunde bei Verdacht auf sJIA. Verlauf: Initial antibiotische Therapie einer Harnwegsinfektion bei Nachweis von E. coli sowie einer Clostridienenteritis. Jedoch erhöhte Biomarker für Inflammation sowie Fieber und im Verlauf arthritische Beschwerden. Zudem wiederkehrende Exantheme. Nach Ausschluss einer paraneoplastischen Ursache und eines Makrophagenaktivierungssyndrom (Knochenstanze, Ganzkörper-MRT) Diagnosestellung einer sJIA. Therapiebeginn mit Methylprednisolon und anschließend orale Dauertherapie (Reduktionsschema). Darunter Rezidiv (auch nach 2. Puls). Indikationsstellung zur Biologikatherapie. IL-1ß Blockade mit Anakinra über 10 Tage, jedoch unzureichendes Ansprechen (trotz Dosiserhöhung nach 1 Woche). Therapieumstellung am Tag 27 auf IL-6-Blockade (Tocilizumab) mit klinisch sehr gutem Erfolg und rückläufigen Inflammations-Biomarkern, jedoch anaphylaktische Reaktion bei der 2. Gabe. Daraufhin Umstellung auf IL-1ß-Blockade mit Canakinumab mit langsamen Ansprechen jedoch zunächst weiterer Steroidabhängigkeit. Unter zusätzlich T-Zell-targeted Therapie mit Mykophenolat-Mofetil zufriedenstellender Verlauf. Steroidreduktion und Absetzen der Steroide unter Stabilisierung der Nebennierenfunktion im Verlauf möglich. Aufgrund des sehr frühen Beginns der Autoinflammation und des schweren therapierefraktären Verlaufes Durchführung erweiterter immunologischer Diagnostik und Bestimmung der Interferonsignatur. Es zeigte sich bei Lymphozytose mit Aktivierung immunologisch kein Hinweis auf eine primäre humorale oder zelluläre Immundefizienz bei wiederholt starker Typ 1 Interferon-Aktivierung im Blut. Diese auffällige Steigerung der Interferonsignatur ist bei monogenen Interferonopathien beschrieben, aber auch bei mono-und polygenen Autoimmunerkrankungen. Im Whole Exome Sequencing konnte keine monogene Ursache für die frühe, schwerverlaufende autoinflammatorische Erkrankung gefunden werden. Zusammenfassung: Schwere und frühe Verlaufsformen einer sJIA stellen eine interdisziplinäre und therapeutische Herausforderung dar. Ein autoinflammatorisches Geschehen im frühesten Kindesalter sollte auch an seltene Immundefizienz-Syndrome denken lassen.

Zielsetzung: Die Kommission ProKind der Gesellschaft für Kinder-und Jugendrheumatologie ( GKJR) hat evidenz-und konsensbasierte Protokolle für die Diagnostik und Therapie von Kindern und Jugendlichen mit definierten rheumatischen Erkrankungen entwickelt [1] [2] [3] [4] [5] . Diese sollen der Harmonisierung der Behandlung rheumakranker Kinder und Jugendlicher dienen und durch eine begleitende Evaluation Erkenntnisse zur Effektivität bestimmter Therapiestrategien liefern. In ProKind-Rheuma wird untersucht, ob die Handlungsprotokolle im klinischen Alltag Einsatz finden und wie deren Ergebnisqualität aussieht. Methoden: ProKind-Rheuma ist eine multizentrische prospektive nichtinterventionelle Beobachtungsstudie. Eingeschlossen werden DMARDnaive, innerhalb der letzten 6 Monate diagnostizierte Patienten mit juveniler idiopathischer Arthritis ( JIA), juvenilem systemischen Lupus erythematodes (jSLE) oder juveniler Dermatomyositis (jDM). Innerhalb von bis zu 15 Monaten werden die Patienten bis zu 5 mal standardisiert untersucht und befragt. Die ärztlichen Befunddokumentationen sowie patienten-und elternberichteten Angaben umfassen krankheitsspezifische validierte Instrumente zur Bewertung von Krankheitsaktivität (z. B. cJADAS10, SLEDAI2k, DAS) und Damage sowie generische zur Erfassung der individuellen Krankheitslast. Introduction: Antibiotic-refractory Lyme arthritis ( ARLA) is defined by persistent arthritis after sufficient antibiotic treatment of acute Lyme arthritis and is seen in approximately 10 % of patients with Lyme arthritis. Although some clinical and genetic risk markers for ARLA have been elucidated, the disease pathogenesis is still inadequately understood. In detail, whether chronic inflammation is sustained by persistent borrelial antigens or triggered by autoantigens is not elucidated yet. Objectives: Identifying the cellular correlate of ongoing immune responses in the inflamed joints of children with ARLA to elucidate antigen targets and disease specific pathomechanisms. Methods: Flow cytometric analysis of T and B cell populations in synovial fluid ( SF) samples of children with ARLA and juvenile idiopathic arthritis ( JIA). High-throughput sequencing of the T cell receptor β ( TCR Vβ) repertoire of SF T cells and single cell immunoglobulin expression cloning of SF B cells in children with ARLA and JIA. Results: Multidimensional flow-cytometric analysis revealed a striking expansion of an IL-21 and IFN-γ co-expressing PD-1hiCXCR5-HLA-DR+ CD4+ T cell population resembling peripheral T helper ( TPH) cells in the joints of pediatric ARLA patients compared to JIA patients. Indeed, ARLA patients display the highest frequencies of TPH cells, which could separate this group of patients from JIA. Accumulating TPH cells exhibited signs of clonal expansion with restricted TCR clonotypes. Those clonotypes showed an overlap between different ARLA patients but not to JIA patients. Furthermore, distinct molecular patterns within the TCR Vβ repertoires diverged in ARLA and JIA patients. Paralleling the observations made in the T cell compartment, accumulating SF B cells showed oligoclonal expansion and almost exclusively displayed the phenotype of CD21lo/-CD11c+ doublenegative ( DN) B cells. Conclusion: The inflamed joints of children with ARLA are characterized by a striking expansion of oligoclonal TPH cells and DN B cells. The distinct features of the TCR Vβ repertoire of TPH from ARLA patients suggest that disease specific immune response may sustain chronic inflammation in ARLA. Having defined the cellular subsets of an ongoing immune response in the joints of children with ARLA, current experiments are ongoing to dissect whether this maladaptive immune response targets persisting Borrelial antigens or rather autoantigens.

Patienten mit einem TINU-Syndrom fallen typischerweise initial entweder durch erhöhte Nierenretentionsparameter, tubuläre Proteinurie, normoglykämische Glukosurie oder klinische Zeichen der Niereninsuffizienz auf [1, 3] . Außerdem beschrieben ist eine inflammatorische okuläre oder auch eine B-Symptomatik. In 65 % der Fälle geht die interstitielle Nephritis der Uveitis um durchschnittlich drei Monate voraus, bei 20 % der Patienten stellt die Uveitis die Erstmanifestation dar [2] . Die Therapie basiert auf einer Immunsuppression -in der Regel initial mit Kortikosteroiden. Verlauf: Wir berichten über drei jugendliche Patienten, zwei davon männlich, im Alter von 15-17 Jahren mit einem TINU-Syndrom. Bei allen drei Patienten bestand initial ein deutliches Krankheitsgefühl mit reduziertem Allgemeinzustand, Müdigkeit, Abgeschlagenheit, Kopfschmerzen sowie ein Appetit-und Gewichtsverlust. Paraklinisch fielen bei Erkrankungsbeginn jeweils deutlich erhöhte Retentionsparameter sowie in zwei Fällen eine (renale) arterielle Hypertonie auf. Eine Nierenbiopsie sicherte in allen Fällen die Diagnose. Bei zwei Jugendlichen trat die TIN parallel zur Uveitis auf. In einem Fall ging die tubuläre interstitielle Nephritis der Uveitis um vier Monate voraus. Bei den männlichen Patienten war die renale arterielle Hypertonie und die damit einhergehenden teilweise ausgeprägten Cephalgien klinisch führend. Die Patientin wies initial eine bilaterale Uveitis intermedia auf und entwickelte im Verlauf eine chronische Niereninsuffizienz. In allen drei Fällen wurde eine systemische Methylprednisolonstoßtherapie mit anschließendem Prednisolon-Tapering durchgeführt. Bei einem Patienten war die Nierenfunktion zwei Jahre nach Diagnosestellung normalisiert. Im Fall des zweiten Patienten ist -drei Monate nach Therapiebeginn -wieder eine Progredienz der Nierenretentionswerte zu verzeichnen. Die Uveitis war in allen Fällen unter Kortikoidtherapie vollständig regredient. Diskussion: Das TINU-Syndrom stellt eine seltene, aber wichtige Differentialdiagnose bei unklarer Nephritis/Uveitis dar. Aufgrund des nur selten gleichzeitigen Auftretens beider Manifestationen ist eine Diagnosestellung erschwert. Es existieren bisher keine internationalen evidenzbasierten Therapieempfehlungen. Das Ansprechen auf eine systemische Kortikoidmonotherapie ist in der Regel sehr gut. Weitere immunsuppressive Medikamente können notwendig werden. Differentialdiagnostisch schwierig kann die Abgrenzung zur Sarkoidose sowie zum Systemischen Lupus erythematodes sein.

Background: Juvenile systemic sclerosis (jSSc) is a rare disease with a prevalence of around 3 in 1,000,000 children. To better capture the clinical manifestations of jSSc the juvenile systemic sclerosis inception cohort (jSScC) has been prospectively enrolling patients with predetermined clinical variables over the past 12 years. One of the goals is to study the demographic, clinical features, and physician and patient reported outcome differences between those with juvenile limited cutaneous (lc) compared to diffuse cutaneous (dc) disease subtypes, to determine if characteristics are similar or different between dc and lc jSSc. Objectives: Evaluation of the baseline clinical characteristics of jSSc patients in the jSScC. Compare clinical phenotype between diffuse (dcjSSc) and limited cutaneous (lcjSSc) subtypes. Methods: Demographic, physical examination, organ system evaluation, autoantibody profile, treatment, and patient and physician reported outcome variables were evaluated from the jSSc Inception cohort and summary statistics applied using chi-square test and Mann Whitney U-test comparing lcjSSc and dcjSSc subtypes. Results: At the time of data extraction, 187 jSSc patients were enrolled in the cohort, 80 % were Caucasian and 80 % female. Diffuse cutaneous jSSc subtype predominated (72 %). Median Disease duration was 2.5 years (1-4.4) . Median age at Raynaud's was 10.4 years (7.2-13.1) and median age of first non-Raynaud's was 10.9 (7.4-13.5). Significant differences were found between dcjSSc versus lcjSSc, regarding several clinical characteristics. Patients with diffuse cutaneous subtype had significantly higher modified Rodnan skin score (p < 0.001), presence of sclerodactyly (p = 0.003), presence of Gottron's papules (p = 0.008), presence of telangiectasia (p = 0.005), history of digital tip ulceration (p = 0.001). Cardiac involvement was significantly higher in limited cutaneous jSSc subtype (p = 0.001). Diffuse cutaneous jSSc patients had significantly worse scores for Physician Global Assessment of disease activity (35 vs 20; p < 0.001) and disease damage (30 vs 15; p < 0.001). Conclusion: Results from this large international cohort of jSSc patients demonstrate significant differences between dcjSSc and lcjSSc patients. According to the general organ involvement and physician global scores, the dcjSSc patients had significantly more severe disease. These observations strengthen our previous findings of the unique organ pattern of pediatric patients. Funding: Supported by the "Joachim Herz Stiftung" Introduction: Salivary gland ultrasound ( SGUS) in symptomatic paediatric patients with systemic erythematosus lupus ( JSLE), Sjogren's disease (jSS) and mixed connective tissue disease ( MCTD) show abnormalities in up to 96 % of patients [1] . Objectives: Semi-quantitative SGUS scoring tools of B-Mode ( BM) SGUS findings have been shown to be feasible and accurate [2] . We performed the first systematic evaluation of SGUS hypervascularisation as a marker of inflammation in paediatric patients, using the OMERACT SGUS vascularity scoring tool used in adult patients [3] .

We report 7 patients with JSLE, jSS or MCTD with or without sicca or parotitis symptoms who underwent SGUS with BM and PD with a linear high-frequency transducer. We used the following semiquantitative scores: Vascularization: Grade 0: no visible vascular signals; Grade 1: focal, dispersed vascular signals; Grade 2: diffuse vascular signals detected in less than 50 % of the gland; Grade 3: diffuse vascular signals in more than 50 % of the gland. B-Mode: Grade 0: normal parenchyma; Grade 1: mild inhomogeneity without anechoic or hypoechoic areas and hyperechogenic bands; Grade 2: moderate inhomogeneity with focal anechoic or hypoechoic areas; and Grade 3: severe inhomogeneity with diffuse anechoic or hypoechoic areas occupying the entire gland or a fibrous gland. Results: Of the 7 patients, 5 had MCTD ± jSS, 1 had jSS and 1 JSLE in a sex distribution of 6 female:1 male. Four had current sicca symptoms. All patients had pathological SGUS findings, even in the absence of current symptoms. Five patients had SGUS BM Grade 3 changes, 1 had Grade 2 and 1 had Grade 1 changes. For PD, 2 patients had Grade 3, 3 had Grade 2 and 1 patient had Grade 1 and 1 patient Grade 0 changes. Of the 3 patients without clinical symptoms, BM changes of Grade 2 (n = 1) and Grade 3 (n = 2) were identified, and PD changes of Grade 1, 2 and 3 in 1 patient each. Analysis of SGUS BM and PD grading showed a correlation coefficient of 0.91. Conclusion: This preliminary investigation of SGUS-vascularisation in paediatric patients showed good correlation with BM findings even in the absence of clinical symptoms, suggesting a role for performing SGUS routinely as part of the diagnostic workup. Further studies in paediatric patients are necessary to confirm our findings.

Objectives: Juvenile-onset systemic lupus erythematosus (jSLE) affects 15-20 % of lupus patients. When compared to adult-onset SLE, it is characterized by increased organ involvement and damage, and higher need for immunosuppressive treatment. Clinical heterogeneity between ethnicities, age groups and individual patients suggest variable pathophysiology. This study aimed at the definition of patient sub-cohorts with "genetic" vs. "classical" SLE to allow individualized care. Methods: Applying target enrichment and new generation sequencing, jSLE patients (N = 348) from the UK JSLE Cohort Study were screened for disease-causing mutations. Findings were integrated with demographic and clinical data, including SLEDAI, pBILAG organ domain and SLICC damage scores. Results: Approximately 5.5 % of jSLE patients carried disease-causing mutations, primarily affecting nucleic acid sensing and metabolism (68 %), immune complex clearance (11 %), their combination (11 %), immune cell (5 %) and NFκB signalling (5 %). When compared to "classical" SLE, "genetic SLE" patients were younger, and exhibited less organ involvement and damage (neuropsychiatric, haematological, gastrointestinal). Notably, neuropsychiatric involvement developed over time. When compared to the remaining cohort, "genetic SLE" associated with anti-dsDNA antibody positivity at diagnosis, and reduced ANA, anti-LA and anti-Sm antibody positivity at last visit. Conclusions: Genetic disease accounts for ≥5.5 % of jSLE cases and associates with young age at onset, and distinct clinical features. As less commonly present after treatment induction, in "genetic SLE", autoantibody positivity may be a secondary result of tissue damage and explain reduced immune complex-mediated renal and haematological involvement. Routine sequencing will allow for patient stratification, risk assessment, and target-directed treatment with reduced toxicity and increased efficacy. Aus der Pamidronatgruppe wechselten 19 (29 %) Kinder wegen Therapieversagens zu TNFi, wovon 10 Kinder (n = 17; 59 %) nach 6 Monaten und 8 Kinder (n = 12; 67 %) nach 12 Monaten in klinischer Remission waren. Umgekehrt wurden nur 3 Patienten der TNFi Gruppe (12 %) später mit Bisphosphonaten behandelt. Schlussfolgerung: Bei CNO Patienten mit fehlendem Therapieansprechen auf NSAR stellt die immun-modulatorische Therapie mit TNFi oder Bisphosphonaten eine effektive Therapieoption dar. Ein Wechsel von Bis-phosphonaten zu TNFi scheint häufiger als umgekehrt. Ein relativ kleiner Teil der Patienten bleibt therapierefraktär, auch nach Versuch beider Optionen. Prospektive Verlaufsbeobachtungen und randomisierte klinische Studien sind notwendig, um evidenzbasierte Therapieempfehlungen aussprechen zu können und Risikofaktoren für Therapie-schwierige Verläufe zu definieren.

Overlapping clinical features promoted the discussion of whether Kawasaki disease ( KD) and PIMS-TS share pathophysiological features and disease outcomes. Medical records from English patients with KD (2015-02/20, N = 27) and PIMS-TS (02/2020-21, N = 34) were accessed to extract information. Children with PIMS-TS were older and more frequently of minority ethnicity background. PIMS-TS patients more commonly exhibited cytopenias and hyperferritinemia, which associated with diffuse cardiac involvement and functional impairment. In some PIMS-TS cases, cardiac pathology developed late, but outcomes were more favorable. In both, KD and PIMS-TS, baseline coronary diameter was a predictor of outcomes. PIMS-TS treatment more frequently included respiratory and cardiovascular support, and corticosteroids with IVIG. Cardiac involvement in PIMS-TS may be the result of a cytokine storm. Though more severe and diffuse when compared to KD, cardiac involvement of PIMS-TS has a more favorable prognosis, which may, after recovery, mitigate the need for long-term follow up. Hintergrund: Das komplexe regionale Schmerzsyndrom ( CRPS) ist eine Schmerzerkrankung unklarer Ätiologie, die üblicherweise eine Extremität betrifft. CRPS tritt meist nach einem Trauma auf, kann jedoch, vor allem bei Kindern, auch spontan auftreten. Hauptsymptom ist ein außergewöhnlich starker Schmerz. Es kommt zu Veränderungen in Sensorik, Vaso-und Sudomotorik, Trophik und Motorik. Körperwahrnehmungsstörungen und die Ablehnung des betroffenen Körperteils können folgen. Betroffene haben oft starke Berührungsängste und vermeiden zunehmend, die Extremität anzuschauen, anzufassen oder zu berühren. Am Zentrum für Schmerztherapie junger Menschen werden in der Behandlung zwei Konzepte eingesetzt, welche je nach Persönlichkeit und therapeutischer Zielsetzung gemeinsam mit den PatientInnen erarbeitet und durchgeführt werden (Garmischer Therapiekonzept mit aktivierenden und desensibilisierenden Schwerpunkten; Graded Motor Imagery mit imaginativen Anteilen und Spiegeltherapie). Desensibilisierungsmaßnahmen durch den Pflege-und Erziehungsdienst: Der Pflege-und Erziehungsdienst ( PED) nimmt im Garmischer Therapiekonzept eine zentrale Rolle ein. Mehrmals täglich werden desensibilisierende Maßnahmen durchgeführt (z. B. mit dem Handtuch "rubbeln", Igelballmassage, Eincremen, Wechseldusche, kühlende/wärmende Öle). Diese Herangehensweise erfordert primär einen Vertrauensaufbau, damit sich die Kinder und Jugendlichen darauf einlassen können. Nur auf der Grundlage einer stabilen Beziehung kann die Therapie durchgeführt werden. Die Desensibilisierung ist in unterschiedliche Stufen eingeteilt (1: leichte; 2: mittlere; 3: normale Berührung; Einteilung in ½ Stufen). Sollte Stufe 1 noch nicht möglich sein, wird auf Stufe 0,5 begonnen, welche lediglich kurzes Tupfen beinhaltet. Fragestellung und Methodik: Von Interesse ist, ob die Berührungsempfindlichkeit über einen Zeitraum von 3-4 Wochen stationärer interdisziplinär-multimodaler Schmerztherapie abnimmt. Verglichen wurde der Desensibilisierungsscore zu Beginn und am Ende des Aufenthalts von 38 PatientInnen (Mittel 13,3 J.; Spanne 6,3-17,9; 4 ♂; 8 obere, 30 untere Extremität), die im Jahr 2020 mit dem Garmischer Therapiekonzept behandelt wurden. Ergebnisse: Die Desensibilisierungsmaßnahmen als Maß für abnehmende Berührungsempfindlichkeit konnten deutlich gesteigert werden (p < 0,00001), die Schmerzstärke nahm signifikant ab (p = 0,02). Diskussion: Basierend auf einer stabilen und vertrauensvollen Beziehung ist es möglich, mithilfe von desensibilisierenden Maßnahmen die Berührungsempfindlichkeit bei CRPS zu reduzieren, was einen großen Beitrag zur Abnahme der Schmerzstärke und dem Zulassen weiterer Therapien leistet. Aufgrund der räumlichen Nähe, der Alltagsbegleitung und ständigen Präsenz des geschulten PEDs ist die wertvolle therapeutische Aufgabe der Desensibilisierung in dieser Berufsgruppe am besten verortet. Dies sollte in der interdisziplinär-multimodalen Schmerztherapie junger Menschen eingeplant werden.

Deutsches Krankenhausinstitut e. V.: Investitionsfähigkeit der deutschen Krankenhäuser

Jens Spahn im Interview: Ein digitaler Zugang zu allen Leistungen des Staate

Koalitionsvertrag zwischen -CDU

Gesetz für eine bessere Versorgung durch Digitalisierung und Innovation (Digitale-Versorgungs-Gesetz, -DVG)

Management im Gesundheitswesen. Das Lehrbuch für Studium und Praxis Bd. 4

Bürgerliches Gesetzbuch ( BGB) (2013) 630f Dokumentation der Behandlung

Strategy and Structure: Chapters in the History of the Industrial Enterprise

Krankenhausinformationssysteme in Deutschland -Analyse einer Befragung von Entscheidern in Kliniken sowie von KIS-Anwendern und Patienten

Multi-Monitor-Studie "Information Worker's Workplace (IWWP

Digitales Krankenhaus: Große Hoffnungen, ernüchternde Realität

Institut für Qualitätsmessung und Evaluation IQME GmbH: Monitor

European Scorecard zum Stand der Implementierung der elektronischen Patientenakte auf nationaler Ebene -Erstes Update

The impact of electronic health records on time efficiency of physicians and nurses: a systematic review

PricewaterhouseCoopers: Future Health -Bevölkerungsumfrage zur Digitalisierung und Technologisierung im Gesundheitswesen

Der Einfluss der Digitalisierung auf die Arbeitskräftesituation in Deutschland

The ability of the neonatal immune response to handle SARS-CoV-2 infection

COVID-19 in a 26-week preterm neonate

Recurrent pleural effusion without intrathoracic migration of ventriculoperitoneal shunt catheter: a case report

Pleural effusion from intrathoracic migration of a ventriculo-peritoneal shunt catheter: pediatric case report and review of the literature

CSF hydrothorax without intrathoracic catheter migration in children with ventriculoperitoneal shunt

CSF hydrothorax: neither migration of peritoneal catheter into the chest nor ascites. Case report and review of the literature

Hazards Associated with Sitting and Carrying Devices for Children Two Years and Younger

Sudden deaths in adult-worn baby carriers: 19 cases

Infant suffocation associated with the incorrect use of a baby sling

Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: A case series and discussion of epileptogenesis in FIRES

Network for Therapy in rare Epilepsies: Lessons from the past 15 years

Positive Short-Term Effect of Low-Dose Rosuvastatin in a Patient with SYNGAP1-Associated Epilepsy

Chewing induced reflex seizures ("eating epilepsy") and eye closure sensitivity as a common feature in pediatric patients with SYNGAP1 mutations: Review of literature and report of 8 cases

Eating Epilepsy") as A New Additional Clinical Feature in Pediatric Patients with SYNGAP1 Mutations? Review of Literature and Case Report

Genetic and neurodevelopmental spectrum of SYNGAP1-associated intellectual disability and epilepsy

SYNGAP1 Mutation in Focal and Generalized Epilepsy: A Literature Overview and A Case Report with Special Aspects of the EEG

SYNGAP1 mutations: Clinical, genetic, and pathophysiological features

Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support

The REDCap consortium: building an international community of software partners

UCSF Benioff Children's Hospital Oakland, UCSF Benioff Children's Hospital Oakland

Identifying key elements for paediatric advance care planning with parents, healthcare providers and stakeholders: A qualitative study

43715, KV 028 Die komplexe Versorgung auf einer Kinderpalliativstation -Eine Vier-Jahres-Analyse am Kinderpalliativzentrum München

Gian Domenico Borasio 3 , Monika Führer 1 1. RKI Epidemiologischer Steckbrief zu SARS-CoV-2 und COVID-19

RKI Hinweise zur Testung von Patienten auf Infektion mit dem neuartigen Coronavirus SARS-CoV-2

Congenital hernia of cord: an often misdiagnosed entity

Congenital Abdominal Wall Defects

Exomphalos (syn. omphalocele). A review of 45 cases

Omphalocele: treatment options

Acute intestinal obstruction caused by clamping of the intestine in the umbilical cord clamp

Iatrogenic ileal perforation: an accidental clamping of a hernia into the umbilical cord and a review of the published work

The umbilical cord of newborn babies should be clamped at least five centimetres from the abdominal wall

Contemporary management of sigmoid volvulus

Neonatal sigmoid volvulus

Hirschsprung's disease presenting as sigmoid volvulus in a newborn

Sigmoid volvulus in a neonate with imperforate anus

Neonatal sigmoid volvulus: A complication of anal stenosis

Anorectal malformations

Rare diseases in the time of covid-19: once forgotten, always forgotten?

43928, FV 040 Inhibition der NETosis durch Surfactant -neue Wege zur Therapie der Entzündung

Reliability and predictive validity of the Standardized Infant NeuroDevelopmental Assessment neurological scale

Standardized Infant NeuroDevelopmental Assessment developmental and socio-emotional scales: reliability and predictive value in an at risk population

Wie beeinflusst die COVID-19-Pandemie die laufende Nicht-COVID-19-Forschung zu Kinder-und Jugendgesundheit? Ergebnisse einer Ad-hoc-Befragung von Forschenden der Förderinitiative "Gesund -ein Leben lang

Psychological Health and Physical Activity Levels during the -COVID-19 Pandemic: A Systematic Review

Impact of the -COVID-19 pandemic on quality of life and mental health in children and adolescents in Germany

Fitbit Staff Activity bounces back as lockdwons lift, but some healthy gains are slipping

World Health Organization 2020 guidelines on physical activity and sedentary behaviour

More active people for a healthier world

Systematic review of the relationships between physical activity and health indicators in the early years (0-4 years)

Cochrane Handbook for Systematic Reviews of Interventions

Preferred reporting items for systematic review and meta-analysis protocols (-PRISMA-P) 2015 statement

The -PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Effects of -COVID-19 Lockdown on Lifestyle Behaviors in Children with Obesity Living in

Effect of the -COVID-19 lockdown on physical activity and sedentary behaviors in French children and adolescents: New results from the -ONAPS national survey

Reduced Physical Activity During -COVID-19 Pandemic in Children With Congenital Heart Disease

Changes in lifestyle behaviours during theCOVID-19 confinement in Spanish children: A longitudinal analysis from theMUGIproject. Pediatric Obesity

Early effects of the COVID-19 pandemic on physical activity and sedentary behavior in children living in the US

Physical Activity, Sedentary Behavior, Sleep and Self-Regulation in Spanish Preschoolers during the -COVID-19 Lockdown

The Impact of COVID-19 on Health Behavior, Stress, Financial and Food Security among Middle to High Income Canadian Families with Young Children

Effect of COVID-19-Related Home Confinement on Sleep Quality, Screen Time and Physical Activity in Tunisian Boys and Girls: A Survey

Lifestyle Changes and Determinants of Children's and Adolescents' Body Weight Increase during the First COVID-19 Lockdown in Greece: The COV-EAT Study

Contextualizing Parental/Familial Influence on Physical Activity in Adolescents before and during COVID-19 Pandemic: A Prospective Analysis

The Impact of Physical Distancing Policies During the COVID-19 Pandemic on Health and Well-Being Among Australian Adolescents

Changes of Physical Activity and Ultra-Processed Food Consumption in Adolescents from Different Countries during Covid-19 Pandemic: An Observational Study

COVID-19 SOCIAL ISOLATION IN BRAZIL: EFFECTS ON THE PHYSICAL ACTIVITY ROUTINE OF FAMILIES WITH CHILDREN

Levels and Changes of Physical Activity in Adolescents during the COVID-19 Pandemic: Contextualizing Urban vs

Health-Related Behaviors Among School-Aged Children and Adolescents During the Spanish Covid-19 Confinement. Front Pediatr 8

Physical activity and screen time of children and adolescents before and during the COVID-19 lockdown in Germany: a natural experiment

Immediate Psychological Effects of the -COVID-19 Quarantine in Youth From Italy and Spain

Barriers and facilitators to changes in adolescent physical activity during COVID-19

Impact of the COVID-19 virus outbreak on movement and play behaviours of Canadian children and youth: a national survey

Healthy movement behaviours in children and youth during the COVID-19 pandemic: Exploring the role of the neighbourhood environment

Changes in Healthy Behaviors and Meeting 24-h Movement Guidelines in Spanish and Brazilian Preschoolers, Children and Adolescents during the COVID-19 Lockdown

Psychological Symptoms and Behavioral Changes in Children and Adolescents During the Early Phase of COVID-19 Quarantine in Three European Countries

Physically Isolated but Socially Connected: Psychological Adjustment and Stress Among Adolescents During the Initial COVID-19 Crisis

Is Physical Activity Associated with Mental Health among Chinese Adolescents during Isolation in COVID-19 Pandemic?

Bewegungs-Zeugnis 2018 zur körperlichen Aktivität von Kindern und Jugendlichen in Deutschland. Villingen-Schwenningen

Körperliche Aktivität von Kindern und Jugendlichen in Deutschland

Current and COVID-19 Challenges With Childhood and Adolescent Sleep

Effects of screentime on the health and well-being of children and adolescents: a systematic review of reviews

Wheelchair skills training to improve confidence with using a manual wheelchair among older adults: a pilot study

A review of factors influencing participation in social and community activities for wheelchair users

Pediatric rehabilitation: 2. Environmental factors affecting participation

Health in Adapted Youth Sports Study (HAYS): health effects of sports participation in children and adolescents with a chronic disease or physical disability

A systematic review of the psychological and social benefits of participation in sport for children and adolescents: informing development of a conceptual model of health through sport

Sport-2-Stay-Fit study: Health effects of after-school sport participation in children and adolescents with a chronic disease or physical disability

Effects of a School-Based Sports Program on Physical Fitness, Physical Activity, and Cardiometabolic Health in Youth With Physical Disabilities: Data From the Sport-2-Stay-Fit Study

Short-term influence of transfer training among full time pediatric wheelchair users: A randomized trial

Associations of sport participation with self-perception, exercise self-efficacy and quality of life among children and adolescents with a physical disability or chronic disease-a cross-sectional study

Pädiatrie (pädiatrische Hämatologie & Onkologie, pädiatrische Kardiologie und Reha nach Blutstammzelltransplantation)

Expression von Bone Morphogenetic Protein-2 (-BMP-2) während der Knochenentwicklung, der physiologischen Knochenheilung und der durch systemisch appliziertes Wachstumshormon

Prechtl's assessment of general movements: a diagnostic tool for the functional assessment of the young nervous system

S2k-Leitlinie "Kindlicher Knick-Senk-Fuß

Einfluss einer sensomotorischen Einlage auf die Aktivität des M. peroneus longus in der Standphase

Hereditary neuropathies: an update

Cochrane review of the evidence for non-surgical interventions for flexible pediatric flat feet

Hübscher's maneuver in the prognosis of flatfoot

Pediatric Orthopaedics-a system of decision-making

Kongress für Orthopädie und Unfallchirurgie 2013 -Medizinreport

? start=% 2F% 2F*% 5B% 40attr_id% 3D% 27bgbl117s0778.pdf% 27% 5D# __bgbl__% 2F% 2F*% 5B% 40attr_id% 3D% 27bgbl117s0778.pdf% 27% 5D__ 1612639415645. Zugegriffen: 6. Febr

Qualitätssicherung bei der Behandlung von Kindern und Jugendlichen mit Zerebralparese in -SPZ -Eine Qualitätspapier der -DGSPJ in Kooperation mit der vereinigung für Kinderorthopädie und der Gesellschaft für Neuropädiatrie

FV 001 PIMS ("pediatric inflammatory multisystem syndrome

Fälle aus einer norddeutschen Kinderklinik

PO 076 Einfluss der Canakinumab-Dosierung auf die Langzeitwirksamkeit und -sicherheit bei Patienten mit Cryopyrin-assoziierten periodischen Syndromen ( CAPS) -30-Monats-Daten des RELIANCE

¹¹ Klinikum Sankt Georg, ImmunoDeficiencyCenter Leipzig ( IDCL)

Canakinumab for the treatment of autoinflammatory recurrent fever syndromes

PO 078 Langzeitwirksamkeit und -sicherheit von Canakinumab bei Patienten mit TRAPS (Tumor-Nekrose-Faktor-Rezeptor-1-assoziiertem periodischem Fiebersyndrom) -Interimsanalyse des RELIANCE

Klinik für Pädiatrische Hämatologie

ImmunoDeficiencyCenter Leipzig ( IDCL)

Canakinumab for the treatment of autoinflammatory recurrent fever syndromes

43884, PO 080 Recurrent fever, aphtous stomatitis and chronic non

Vergleichende Analyse der Verwendung von Etanercept-Biosimilar und Originalpräparat in der klinischen Praxis: Daten aus dem deutschen BiKeR-Register

Gerd Horneff 1 , Daniel Windschall 2 , Anton Hospach 3 , Sonja Mrusek 4 , Michael Rühlmann 5

Zentrum für Allgemeine Pädiatrie und Neonatologie, Direktor

43649, KV 038 Beeinflusst die Kombination mit Methotrexat das "drug survival" von Biologika bei der polyartikulären JIA

Effects of juvenile idiopathic arthritis on kinematics and kinetics of the lower extremities call for consequences in physical activities recommendations

Gait adaptations in youth with juvenile idiopathic arthritis

DeepLabCut: markerless pose estimation of user-defined body parts with deep learning

DeeperCut: A deeper, stronger, and faster multi-person pose estimation model

ImageNet large scale visual recognition challenge

2D articulated human pose estimation and retrieval in (almost) unconstrained still images

Attikon General Hospital, National and

The influence of overweight and obesity on treatment response in juvenile idiopathic arthritis

Perzentile für den Body-mass-Index für das Kindes-und Jugendalter unter Heranziehung verschiedener deutscher Stichproben

43786, FV 024 Symptome und Outcome einer SARS-CoV-2-Infektion bei Kindern und Jugendlichen mit rheumatischen Erkrankungen -Daten aus der Kinder-Kerndokumentation

The quality of life questionnaire -EQ-5D-5L: psychometric properties and normative values for the general German population

Evaluation of a Rheumatology Transition Clinic

43706, KV 039 Transitional care in rheumatology: current practice in Switzerland Lut Berben

University Children's Hospital Bern, Department of Pediatric Rheumatology

Children's Hospital of Eastern Switzerland, Department of Pediatric Rheumatology

Instituto Pediatrico della Svizzera Italiana, Servizio di reumatologia pediatrica

Standardisierte Bewertung von Behandlung und Outcome bei neu diagnostizierten Patient:innen mit JIA, jSLE und jDM -Erste Daten aus ProKind Sascha Eulert 1 , Martina Niewerth 1

Deutsches Zentrum für Kinder-und Jugendrheumatologie ( DZKJR), Zentrum für Schmerztherapie junger Menschen

Protokolle zur Klassifikation, Überwachung und Therapie in der Kinderrheumatologie (PRO-KIND): Polyartikuläre juvenile idiopathische Arthritis: Ergebnisse der Arbeitsgruppe Polyarthritis in der GKJR-Kommission PRO-KIND

Harmonisierung der Diagnostik und Therapie der systemischen juvenilen idiopathischen Arthritis in Deutschland: Prozessbeschreibung und Kernaussagen

Protokolle zur Klassifikation, Überwachung und Therapie in der Kinderrheumatologie (PRO-KIND): Enthesitis-assoziierte Arthritis: Ergebnisse der Arbeitsgruppe Enthesitis-assoziierte Arthritis in der GKJR-Kommission PRO-KIND

Development of practice and consensusbased strategies including a treat-to-target approach for the management of moderate and severe juvenile dermatomyositis in Germany and Austria

Deutsches Rheuma-Forschungszentrum Berlin

43657, PO 086 Erfahrungen mit Adalimumab-Biosimilars in der klinischen Praxis: Daten aus dem Deutschen BiKeR-Register

Gerd Horneff 1 , Frank Dressler 2 , Michael Rühlmann 3 , Tilmann Geikowski 4 , Sonja Mrusek 5

Medizinische Hochschule Hannover ( MHH)

PO 089 Patients with juvenile systemic sclerosis have a distinct pattern of organ involvement. Results from the juvenile systemic sclerosis inception cohort

Preponderance of CTLA4 Variation Associated with autosomal Dominant Immune Dysregulation in the MYPPPY Motif Front Immunol

Funktion and Role of regulatory T Cells in Rheumatoid Arthritis. Front Immunol

Investigator Meeting

FV 002 Genetic forms of juvenile-onset SLE in the UK

Alder Hey Children's NHS Foundation Trust, Department of Women's and Children's Health, Institute of Life Course and Medical Sciences, Liverpool, United Kingdom functional impairment. In some PIMS-TS cases, cardiac pathology developed late, but outcomes were more favorable. In both, KD and PIMS-TS, baseline coronary diameter was a predictor of outcomes. PIMS-TS treatment more frequently included respiratory and cardiovascular support, and corticosteroids with IVIG. Cardiac involvement in PIMS-TS may be the result of a cytokine storm. Though more severe and diffuse when compared to KD, cardiac involvement of PIMS-TS has a more favorable prognosis

Bisphosphonate oder TNF-Inhibitoren zur Therapie der chronischen nichtbakteriellen Osteomyelitis ( CNO)?

Royal Hospital for Children, Pediatric Rheumatology, Glasgow, Großbritannien; 4 Crosshouse Hospital, Children's Hospital

Alder Hey Children's NHS Foundation Trust, Department of Rheumatology, Liverpool, Großbritannien; 8 University of Liverpool & Department of Rheumatology, Alder Hey Children's NHS Foundation Trust, Department of Women's and Children's Health, Institute of Life Course and Medical Sciences

Labor Berlin-Charité Vivantes GmbH

Kinderkrankenhaus Amsterdamer Straße, Station für chronisch kranke Kinder

Fälle mit PIMS über ein Zusatzmodul erfasst. Ziel dieser Analyse ist die Beschreibung (i) der klinischen Präsentation, (ii) der eingesetzten Therapeutika und (iii) des Outcomes bei Kindern, die an einem PIMS erkrankt sind

Ergebnisse/Zusammenfassung: Bis 18.05.2021 wurden 46 Fälle eines PIMS gemeldet (18 w/28 m). Das mediane Alter bei Symptombeginn lag bei 7 Jahren

Eine arterielle Hypotonie sowie eine Atemnot/Tachypnoe wurde bei jeweils 21 % der Patienten beschrieben. Im Mittel hatten die Patienten 7 [3-14] Symptome. In der Diagnostik zeigte sich bei 80 % der Pat. eine kardiale (32 % Perikarditis/-erguß, 22 % Myokarditis, 22 % Dilatation der Koranarien), bei 52 % eine gastrointestinale (15 % Hepatomegalie, 11 % mesenteriale Lymphadenopathie

Zielsetzung: Das Tumor-Nekrose-Faktor-Rezeptor-1-assoziierte periodische Fiebersyndrom ( TRAPS) ist eine seltene autoinflammatorische Erkrankung, die durch schwerwiegende systemische und Organentzündung gekennzeichnet ist. Im Rahmen der Phase-3-Zulassungsstudie CLUSTER wurden TRAPS-Patienten erfolgreich mit dem Interleukin-1β-Inhibitor Canakinumab ( CAN) behandelt. 45 % der Patienten erreichten nach 16 Wochen eine klinische Remission (primärer Endpunkt) [1] . CAN ist seit 2017 zugelassen und im Einsatz für die Behandlung von TRAPS-Patienten [2] . Die vorliegende Studie untersucht die Langzeitwirksamkeit und -sicherheit von CAN unter Routinebedingungen der klinischen Praxis bei pädiatrischen (≥ 2 Jahre) und erwachsenen TRAPS-Patienten. Methode: RELIANCE ist eine in Deutschland durchgeführte, prospektive, nicht-interventionelle, multizentrische Observationsstudie. Eingeschlossen werden Patienten mit klinisch bestätigter TRAPS-Diagnose, die routinemäßig CAN erhalten. Zur Baseline und in 6-monatigen Intervallen erfolgt die Evaluation der Sicherheit und Wirksamkeit von CAN mittels klinischer Daten, Arzt-und Patienten-berichteter Krankheitsaktivität. Ergebnisse: Die Interimsanalyse von 16 TRAPS-Patienten, die bis Dezember 2020 eingeschlossen wurden (ein Patient mit atypischem TRAPS), beinhaltet Baseline-Daten und vorläufige 18-Monatsdaten. 11 Patienten (69 %) waren weiblich. Das mediane Alter zur Baseline lag bei 23 Jahren (3-43 Jahre), die mediane Dauer der vorherigen CAN-Therapie bei 1 Jahr (0-4 Jahre). 10 Patienten (62,5 %) waren mit Anakinra vorbehandelt und ein Patient (6,3 %) mit Tocilizumab. Gemäß Arzteinschätzung befanden sich 60 % (Baseline) bis 80 % (18-Monatsvisite) der Patienten in Remission und gemäß PGA (physician global assessment) 40 % der Patienten zur Baseline und 80 % zur 18-Monatsvisite ohne Krankheitsaktivität. Die Patientenbewertung der aktuellen Krankheitsaktivität ( VAS 0-10, median) sank von 1,5 (Baseline) auf 0 (18-Monatsvisite). 50 % der Patienten gaben allerdings an, in ihrem Sozialleben durch die Krankheit beeinträchtigt zu sein. Die Laborparameter CRP und SAA befanden sich zu jedem Zeitpunkt im Normbereich. Insgesamt traten 7 unerwünschte Ereignisse auf, von denen keines als schwerwiegend oder therapie-bedingt eingestuft wurde. Zusammenfassung: Die Baseline-Charakteristika und Interimsdaten der TRAPS-Patienten in der RELIANCE-Studie weisen auf einen sicheren und effektiven Einsatz von CAN bei TRAPS hin. Weitere Interims-und Studie-nendergebnisse werden analysiert, um die Wirksamkeit und Sicherheit der Langzeit-CAN-Therapie bei diesen Patienten zu evaluieren. Zielsetzung: Periodische Fiebersyndrome wie HIDS/ MKD (Hyper-IgD-Syndrom/Mevalonat-Kinase-Defizienz) sind seltene autoinflammatorische Erkrankungen, die durch schwerwiegende systemische und Organentzündungen charakterisiert sind. Eine erfolgreiche Therapie mit schneller Remission der Symptome und Normalisierung der Laborparameter konnte bei den meisten Patienten mit dem Interleukin-1β-Inhibitor Canakinumab ( CAN) sowohl in klinischen Studien [1] als auch in der klinischen Routine erzielt werden. CAN ist seit 2017 für die Behandlung von HIDS/ MKD-Patienten zugelassen [2] . Die vorliegende Studie untersucht die Langzeitwirksamkeit und -sicherheit von CAN unter Routinebedingungen der klinischen Praxis bei pädiatrischen (≥ 2 Jahre) und erwachsenen HIDS/ MKD-Patienten. Methode: RELIANCE ist eine in Deutschland durchgeführte, prospektive, nicht-interventionelle, multizentrische Observationsstudie mit einer 3-jährigen Follow-up-Periode. Eingeschlossen werden Patienten mit klinisch bestätigter HIDS/ MKD-Diagnose, die routinemäßig CAN erhalten. Zur Baseline und in 6-monatigen Intervallen erfolgt die Evaluation der Sicherheit und Wirksamkeit von CAN mittels klinischer Daten, Arzt-und Patienten-berichteter Krankheitsaktivität. Ergebnisse: Die Interimsanalyse der HIDS/ MKD-Patienten, die bis Dezember 2020 eingeschlossen wurden, beinhaltet Baseline-Daten von 7 Patienten, vorläufige 6-Monatsdaten von 6 Patienten und vorläufige 12-Monatsdaten von 4 Patienten. Das mediane Alter zur Baseline lag bei 7 Jahren (2-39 Jahre), 4 Patienten (57 %) waren weiblich. Die mediane Dauer der vorherigen CAN-Therapie betrug 2 Jahre (0-5 Jahre). Zur Baseline/6-Monatsvisite/12-Monatsvisite waren laut Arztbewertung 57/83/75 % der Patienten in Remission und 43/83/75 % der Patienten ohne nachweisbare Krankheitsaktivität. Die Patientenbewertung der aktuellen Krankheitsaktivität (median, VAS 1-10) betrug zur Baseline/6-Monatsvisite/12-Monatsvisite 0/1/0,5; die der Fatigue (median, VAS 1-10) 2/1,5/2,5. Der Anteil der Patienten ohne Beeinträchtigung ihres Soziallebens durch die Erkrankung stieg von 40 % zur Baseline auf 100 % zur 12-Monatsvisite. Die Laborparameter (c-reaktives Protein und Serum Amyloid A) befanden sich zu jedem Zeitpunkt im Normalbereich. 3 Patienten erlitten therapiebedingte unerwünschte Ereignisse auf, von denen keines als schwerwiegend eingestuft wurde. Zusammenfassung: Die Baseline-Charakteristika und Interimsdaten der HIDS/ MKD-Patienten in der RELIANCE-Studie weisen auf eine gute Krankheitskontrolle anhand der klinischen und der Laborparameter hin. Im Rahmen der 12-Monats-Interimsanalyse traten keine unerwarteten Sicherheitsaspekte auf.warteten JIA-Fälle erfasst, im Jahr 2019 waren das über 7700 Fälle. Hierbei sind Erstmanifestationen im Säuglingsalter die absolute Ausnahme. Methodik: Alle in der Kinder-Kerndokumentation im Jahr 2019 erfassten Patient* innen mit einer JIA und einem Erkrankungsbeginn vor dem vollendeten ersten Lebensjahr wurden ermittelt. Die Charakteristika der Patient* innen mit oligo-und polyartikulärer JIA werden detaillierter beschrieben. Kinder mit persistierender Monarthritis wurden ausgeschlossen. Exemplarisch zeigen wir die Krankheitsgeschichte dreier Säuglinge verschiedener Zentren. Ergebnisse: Von den 7739 in der Kerndokumentation im Jahr 2019 erfassten JIA-Fällen waren 40 (0,5 %) im ersten Lebensjahr erkrankt. Die Mehrzahl dieser Patient* innen hatte eine Oligoarthritis, 28 % wiesen eine Polyarthritis auf. 2/3 der Betroffenen waren weiblich und vornehmlich ANA-positiv (58 %). Zum Dokumentationszeitpunkt betrug die mittlere Krankheitsdauer 8,2 Jahre. Die Behandlung erfolgte in 17 % mit NSAR, in 32 % mit MTX und in 38 % mit Biologika. 15 % hatten bereits eine Uveitis durchgemacht. 53 % der Betroffenen befanden sich zum Erhebungszeitraum in Remission (JADAS10 ≤ 1). Die exemplarisch dargestellten Patient* innen waren zu Symptombeginn 5, 9 und 10 Monate alt und zeigten im Verlauf einen polyartikulären Gelenkbefall. Die Remission konnte durch Methotrexat bzw. Etanercept erreicht werden. Zusammenfassung und Ausblick: Die JIA im Säuglingsalter bleibt eine seltene Entität, insbesondere mit einer polyartikulären Manifestation. Diese seltene Differentialdiagnose muss bedacht werden, wenn Säuglinge durch Bewegungsarmut auffallen und keine generalisierten Zeichen einer Inflammation (Fieber, Exanthem, etc.) aufweisen. Die JIA im Säuglingsalter spricht in der Regel gut auf herkömmliche antientzündliche Therapien an. Wir planen, alle Zentren, welche Säuglinge in der Kerndokumentation gemeldet haben, zu kontaktieren, um die JIA mit Beginn im Säuglingsalter detaillierter zu charakterisieren. Unser Ansatz einer markerlosen, robusten, kostengünstigen und anpassungsfähigen Ganganalyse-Methode für jedes Alter kann dazu beitragen, Bewegungen besser zu verstehen, unser Wissen über die funktionellen Ganganomalien bei JIA zu erweitern und das Outcome zu verbessern.

Objectives: By entering inflamed tissues, T cells adapt to low levels of oxygen, lack of key nutrients and oxidative stress conditions. To study how this environment affects T cells, we analyzed T cell metabolism and function in synovial fluid cells from Juvenile Idiopathic Arthritis ( JIA) patients. We aimed to investigate how oxidative stress regulates T cell responses within inflamed joints of JIA patients and analyzed Nrf2-the key regulator of the antioxidative stress response-and it's signaling pathways. Materials and Methods: Flow cytometry analyses were performed to determine oxidative status and metabolic characteristics in the mononuclear cells from arthritic joint and peripheral blood of JIA patients. Seahorse assay were performed to analyze their metabolic activity. qRT-PCR were performed to analyze expression of genes involved in glucose and fatty acid metabolism.

We identified high ROS levels in CD4+ T cells from synovial fluid ( SF). Nrf2 and its target gene Nqo1 were less expressed in SF compared to blood CD4+ T cells. SF CD4+ T cells expressed high levels of mitochondrial mass, high glucose uptake and ECAR levels and high fatty acid uptake. Vice versa, Nrf2 activation of SF T cells yielded in downregulation of ROS, ECAR and fatty acid uptake and also reduced secretion of IFN-g. These findings suggest that Nrf2 signaling regulates the metabolism of SF T cells and its dysregulation in T cells during chronic inflammation could contribute to disease progression. 4 %), t1 (7 % vs. 3 %) und t2 (6 % vs. 3 %) häufiger unter der 3. Perzentile der Normalbevölkerung als die der Kontrollen. 90 % der zu t0 normalgewichtig klassifizierten Patienten behielten im Krankheitsverlauf ihren Gewichtsstatus bei. Zu t1 gehörten 30 % und zu t2 40 % der zum Einschluss übergewichtigen Patienten nun den Normalgewichtigen an. Im Zwei-Jahres-Verlauf wiesen 51 % der bei Einschluss im Längenwachstum verzögerten Patienten keine Auffälligkeiten mehr auf ( ΔSDS t0-t2 = +0,07, p = 0,03). Unter DMARD-naiven Patienten (ohne sJIA) zeigte sich bei 42 % der Normalgewichtigen und 50 % der Übergewichtigen eine erhöhte BSG (> 20 mm/h). Der Nachweis eines erhöhten CRP-Wertes (> 10 mg/l) ließ sich bei Übergewichtigen am häufigsten erbringen. Beide Entzündungsparameter waren auch in der Gruppe klinisch inaktiver Patienten (t1) bei Übergewichtigen häufiger erhöht als bei Normal-und Untergewichtigen. Zu t0 übergewichtige Patienten erreichten verglichen zu unter-und normalgewichtigen im Krankheitsverlauf weniger häufig Beschwerdefreiheit ( CHAQ = 0) und den Status einer inaktiven Erkrankung (cJADAS-10 ≤ 1 sowie PGA < 1), insbesondere Übergewichtige mit polyartikulärem Verlauf.

Zielsetzung: Eine rheumatische Grunderkrankung und die einhergehende immunsuppressive Therapie könnten auch für Kinder und Jugendliche, die ansonsten meist milde und mit gutem Outcome an COVID-19 erkranken, das Risiko für einen schwereren Verlauf sowie ein schlechteres Outcome von COVID-19 erhöhen. Weiterhin könnte eine SARS-CoV-2-Infektion zu einem Schub der Grunderkrankung führen. Methoden: Mittels eines spezifischen, in die Kinder-Kerndokumentation implementierten SARS-CoV-2-Fragebogens wurden u. a. folgende Parameter erfasst: Alter, Geschlecht, Diagnose, SARS-CoV-2-Testmethode, Grund der Testung, Symptome, Krankheitsverlauf, Behandlung und Outcome von COVID-19, medikamentöse Therapie sowie Aktivität der Grunderkrankung (Numerische Rating Skala ( NRS) 0-10) vor/nach der SARS-CoV-2-Infektion. Aus dem "Biologika in der Kinderrheumatologie-Register" (BiKeR), in dem bei Patienten eine SARS-CoV-2-Infektion als ESI erfasst wurde, sowie aus dem Register für hospitalisierte Kinder und Jugendliche mit SARS-CoV-2-Infektion der Deutschen Gesellschaft für Pädiatrische Infektiologie, wurden Fälle dieser Datensammlung zugeführt. Ausgewertet wurden alle bis 26 Die juvenile amyopathische Dermatomyositis ( JADM), auch als juvenile Dermatomyositis sine Myositis bekannt, ist eine seltener Subtyp der klassischen juvenilen Dermatomyositis ( JDM) bei der typische Hautmanifestationen vorliegen, während klinische und laborchemische Zeichen der Muskelentzündung definitionsgemäß fehlen. Wir stellen einen sieben Jahre alten Jungen vor, bei dem seit einem Jahr rezidivierend auftretende periorbitale Erytheme sowie Hautveränderungen über den Streckseiten beider Hände aufgefallen waren. Der im Alltag aktive Junge beklagte keine Muskelschwäche oder Muskelschmerzen. Die ausführliche klinische, bildgebende und laborchemische Diagnostik ergab neben charakteristischen periorbitalen Ödemen, klassische Gottron Papeln an den Streckseiten der Finger. Die Childhood Myositis Assessment Scale ( CMAS) war mit 48 von 52 Punkten unauffällig. Im Labor zeigten sich die Muskelenzyme normwertig, bei jedoch positivem Nachweis Myositis-spezifischer Jo-1-Antikörper. In der Sonographie präsentierte sich die Muskulatur der oberen sowie unteren Extremität unauffällig, vor allem ließen sich keine Myositis-spezifischen Veränderungen nachweisen. In Zusammenschau der erhobenen Befunde konnte anhand des typischen Hautphänotyps und der Jo-1-Positivität die Diagnose einer JADM gestellt werden. Bei der JADM handelt es sich um einen seltenen, bisher wenig untersuchten Subtyp der JDM. In der Literatur liegen demnach keine standardisierten diagnostischen oder therapeutischen Strategien vor. Trotz klinischen und bildmorphologischen Ausschlusses einer klassischen Myositis kann jedoch bei Vorliegen klassischer Hautmanifestationen in Kombination mit anderen Kriterien (hier: Myositis-assoziierte Antikörper) die Diagnose gestellt werden. Therapeutisch wurden im vorliegenden Fall lediglich topische Steroide zur lokalen Inflammationskontrolle eingesetzt. Für eine intensive Standardtherapie mit systemischen Steroiden, intravenösen Immunglobulinen und einer DMARD-Therapie finden sich auf der Basis der aktuellen Literatur keine Hinweise. Da bis zu 25 % der JADM auch in klassische JDM übergehen können, sollte ein regelmäßiges Monitoring mittels üblicher klinischer Scores als auch Organ-spezifische Kontrolluntersuchungen (Gelenk, gastrointestinale -, Lungen-und kardiovaskuläre Beteiligung) erfolgen. Ein regelmäßiges Screening in einer Spezialambulanz sollte in jedem Fall erfolgen. (8, 4 ; SD 1,4) war höher als die mit der internistischen Versorgung (7,7; SD 2,2). Im Mittel waren die Befragten für 3,4 h/Woche körperlich aktiv, 61,0 % dabei mindestens 2,5 h/Woche. Erhöhte körperliche Aktivität korrelierte mit besserer HR-QoL und weniger Problemen mit Mobilität, alltäglichen Tätigkeiten und Angst/Niedergeschlagenheit. Zusammenfassung: Patienten mit rheumatischen Erkrankungen fühlen sich nach dem Transfer in ihrer HR-QoL im Vergleich zur Allgemeinbevölkerung beeinträchtigt. Die Behandlungskontinuität unserer Kohorte war besser als in vergleichbaren Studien (74,0 %) [3] , die Zufriedenheit mit der Vorbereitung auf den Transfer war hoch. Unsere Kohorte gab eine überdurchschnittliche körperliche Aktivität an [2] , damit zeigt sich hier der Trend zu mehr körperlicher Aktivität bei rheumatischen Erkrankungen. Chronisch-rheumatische Erkrankungen stellen eine Belastung dar, wobei ein strukturierter, interdisziplinärer Transfer in die Erwachsenenmedizin die Behandlungskontinuität und die Zufriedenheit verbessern kann.

Background: About half of all children with rheumatic diseases need continuous medical care during adolescence and adulthood. A good transition into adult rheumatology is essential. A structured transition process has therefore been recommended by the European League Against Rheumatism ( EULAR) and the Pediatric Rheumatology European Society ( PReS). However, these recommendations are not widely implemented. Aims: To assess the current practice of transitional care ( TC) in Switzerland in relation to EULAR/ PReS recommendations and to describe gaps and challenges in following the recommendations. Methods: All ten pediatric Swiss rheumatology centers and their collaborating adult centers offering transition service to adult care were invited to participate. The responsible pediatric (n = 10) and adult (n = 10) rheumatologist of each center was interviewed separately using a structured manual addressing the EULAR/ PReS transitional care recommendations. Results: All centers implemented parts of the recommendations, however none of the centers implemented all recommendations. Whereas some recommendations were given in all centers: e. g. continuity in healthcare team, consultations focused on adolescents and young adults, and joint consultations between pediatric and adult rheumatologists, other were only implemented in some: e. g. multi-disciplinary approach, the transfer to other disciplines at the same time, defined age for initiating transition and the existence of a transition plan. Despite this, most centers rated the performance of their TC as very good. The participants reported that they do not face major barriers that hinder the implementation of the recommendations. Conclusion: This survey provides evidence on the current structure of TC in Swiss rheumatology centers. The impact of this heterogeneity of TC in Switzerland on young adults' clinical outcomes across centers can be essential. Next, we will study long-term disease outcome of young adults together with the evaluation of patient reported outcomes (e. g. qualityof-life, satisfaction with care) in relationship to the implementation of the EULAR/ PReS recommendations. Background: Juvenile systemic sclerosis (jSSc) is a rare disease with a prevalence of around 3 in 1,000,000 children. To better capture the clinical manifestations of jSSc the juvenile systemic sclerosis inception cohort (jSScC) has been prospectively enrolling patients with predetermined clinical variables over the past 12 years. One of the goals is to study the demographic, clinical features, and physician and patient reported outcome differences between male and female patients, to determine if characteristics are similar or different. Objective: To compare organ involvement and disease severity between male and female patients with juvenile onset systemic sclerosis (jSSc). Methods: Demographics, organ involvement, laboratory evaluation, patient reported outcomes and physician assessment variables were compared between male and female jSSc patients enrolled in the prospective international juvenile systemic sclerosis cohort (jSScC) at their baseline visit. Results: 175 jSSc patients were evaluated, 142 female and 33 male. Race, age of onset, disease duration, and disease subtypes (70 % diffuse cutaneous) were similar between males and females. Active digital ulceration, very low body mass index, and tendon friction rubs were significantly more frequent in males. Physician global assessment of disease severity and digital ulcer activity was significantly higher in males. The composite pulmonary involvement was also more frequent in males, though not statistically significantly. Conclusion: In this cohort, jSSc had a more severe course in males. This reflects the adult-onset SSc cohort data and parallels it in regards to increased digital ulcers, interstitial lung disease, and global severity. Differences from adult findings include no increased signal of pulmonary arterial hypertension or heart failure in male pediatric patients. While monitoring protocols of organ involvement in jSSc need to be identical for males and females, our findings suggest a higher index of suspicion of certain organ involvement in males. Juvenile systemic scleroderma (jSSc) is a rare, but potentially life-threatening disease. Around 45 % of the patients develop interstitial lung disease and this can lead to relevant mortality. Pulmonary function tests ( PFT). Including forced vital capacity ( FVC) and lung carbon monoxide diffusion ( DLCO), are key for the screening of interstitial lung disease. PFT require an optimal patient cooperation and coordination. For example, the patient has to hold the breath for 10 s. Additionally, the graph of the breath holding maneuver has to be carefully observed, if there is a premature expiration, numbers have to be judged with suspicion. We were interested how in the real world these problems are addressed in children. Objective: To assess how PFT is assessed in the participating pediatric rheumatologic centers in the juvenile scleroderma inception cohort Methods: We conducted a survey among the pediatric rheumatologists and associated pediatric pulmonologists, who are participating in the prospective juvenile scleroderma inception cohort (jSScC). We asked them some simple questions about the standard of care regarding assessment of the PFT. In 77 % (20/26) of the centers the respiratory technician that conducts the PFT judges the level of cooperation of the child and the pediatric pulmonologist, who evaluates the results, also makes a judgement on the reliability of the test. We asked a specific question regarding the duration of the breath holding time setting in the lung function system. 32 % (8/25) set the breath holding time under 7 s and 8 % (2/26) at 7 s and 20 % (5/25) between 7 and 10 s and 28 % (7/25) exactly 10 s. Discussion: We could demonstrate that in 96 % of the responding centers PFT are carried out in specialized pediatric pulmonology departments, which are aware of the methodological problems and change their breath holding time to an appropriate time to gain as many reliable tests as possible. There is still a wide range of the applied breath holding time and even in centers carrying for jSSc patients, 23 % do not assess DLCO. [1, 3] . Bei einer CTLA-4 Defizienz (Cytotoxic T-lymphocyte-associated Protein-4 Defizienz) kann es zu einer überschießenden und fehlgeleiteten Immunreaktionen, die neben Infektionsanfälligkeit zu Entzündungen und Autoimmunität führen kann [1] . Das Risiko für Autoimmunerkrankungen, wie Autoimmunzytopenien ( ITP, AIHA), -thyreoditis und -arthritis ist erhöht. Zur Inhibition der CD28-abhängigen T-Zell-Antwort wurde in Im CCI in Freiburg die Therapie mit Abatacept eingeleitet. Mit diesem Medikament wird das fehlende körpereigene CTLA4 als Medikament zugeführt, womit der Mangel teilweise kompensiert, werden kann. Unter Abatacept Progredienz der Symptomatik. Umstellung auf eine intravenöse Therapie mit einem Antikörper gegen CD20 Zellen (Rituximab). Darunter rückläufige Arthritiszeichen. Aus Sorge vor dem weiteren Verlauf, bei extrem frühen Krankheitsbeginn Planung einer Stammzelltransplantation. Fazit: Bei ausgeprägter Arthritis im frühen Säuglingsalter bzw. bei Immundefizienz unklarer Ursache sollten monogenetische Erkrankungen wie eine CTLA-4 Defizienz in Betracht gezogen werden.

The paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 ( PIMS-TS) was first described in April 2020 following the first wave of the COVID-19 pandemic as a hyperinflammatory clinical syndrome in children previously infected with SARS-CoV-2. Although the clinical phenotype resembles that of Kawasaki disease, the two syndromes have been shown to be immunologically distinct and the pathogenesis of PIMS-TS is incompletely understood. Here, we describe the Berlin cohort and provide evidence of the predominance of SARS-CoV-2-specific IgA in patients with PIMS-TS. Methods: Patients presenting with PIMS-TS between November 2020 and May 2021 were included in the study. The clinical data were analysed retrospectively in comparison with a cohort of previously healthy children presenting with a CRP >130 mg/L due to different diagnoses. We collected serum samples from patients with PIMS-TS and patients previously infected with SARS-CoV-2 who did not develop PIMS-TS. Levels of IgG, IgM and IgA against SARS-CoV-2 spike protein and nucleocapsid protein were measured by ELISA. Additionally, the patients' sera were tested for reactivity with myocardial tissue by indirect immunofluorescence microscopy detecting human IgG. Results: We identified 16 confirmed cases of PIMS-TS (6F; 10M) of median age 9.5 years (range: [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . The cohort presented with the following symptoms: fever (100 %), myocardial involvement (100 %), rash (76 %), conjunctivitis (71 %), abdominal pain (59 %), mucositis (53 %), diarrhoea (47 %), cervical lymphadenopathy (41 %), and arterial hypotension (35 %). Laboratory findings included markedly elevated inflammatory and endothelial parameters as well as an increase in cardiac and liver markers. One patient showed mildly elevated monocytic CD169 expression. All patients were treated with intravenous immunoglobulins and acetylsalicylic acid ± glucocorticoids. One patient was refractory to this regimen and subsequently improved with IL-1 blockade. Another patient with a similar clinical phenotype was SARS-CoV-2-seronegative. Simultaneously, we identified 41 children who were hospitalised with a CRP >130 mg/L over the same time period. In comparison with this cohort, patients with PIMS-TS showed higher levels of factor VIII (p = 0.03), NT-pro BNP (p = 0.08) and gamma-GT (p = 0.005). After a median follow-up of 47 days (range: 26-98), many patients showed persistently elevated levels of factor VIII several weeks after resolution of clinical symptoms and normalisation of inflammatory markers. ELISA analyses revealed significantly elevated levels of SARS-CoV-2-specific IgA in the blood of patients with PIMS-TS in comparison with the SARS-CoV-2 seropositive control group. The serum of one patient showed mild reactivity to myocardial tissue. Background: Prompt identification and diagnosis of large vessel vasculitis ( LVV) is necessary to reduce associated morbidity and mortality. Clinical presentation is highly variable and there are ethnic and regional differences in the incidence and prevalence. Paediatric rheumatologists therefore require a high index of suspicion to establish the diagnosis early. Ultrasound ( US) is a quick, non-invasive imaging tool for suspected LVV. Objectives: To demonstrate the utility of US in the diagnosis of LVV. Methods: We report two patients who presented acutely with joint pain and swelling, weight loss, generalized muscular atrophy and a marked acute phase reaction. Fast track ultrasound of the heart and aortic branches was performed as part of the initial diagnostic workup. Results: US findings for Patient 1 (13 year-old female, Turkish ancestry) showed the halo sign in the area of the descending aorta combined with massive aortic dilatation and the aliasing phenomenon in the upper descending aorta. US results for Patient 2 (17 year-old male, Bulgarian ancestry) showed the halo sign in the abdominal aorta with increased aortic flow and stenosis at the outgoing upper mesenteric artery. Blood flow was reduced at the poststenotic site. Additionally, infiltration of the left carotid artery wall was detected. Both patients were transferred to a tertiary paediatric cardiology centre. MRI angiography and PET-MRI in Patient 1 demonstrated inflammatory changes in the wall of the aortic aneurysm. Cardiothoracic surgery with aortic arch grafting was performed. A diagnosis of Behçet's disease was made based on the additional findings of recurrent major oral aphthous ulcers, soft tissue inflammation and HLA-B51 positivity. Patient 2 also underwent MRI and PET-MRI testing which demonstrated extensive inflammatory changes in the thoracic and abdominal aorta and multiple first branch vessels, leading to a diagnosis of Takayasu arteritis. Conclusion: Ultrasound is a useful non-invasive tool for the screening of LVV. Typical findings are related to inflammation of the arteries including (1) intimal oedema forming a hypoechoic ring at the lumen periphery (the "halo sign"); (2) lumen stenosis with corresponding increased systolic blood flow velocity; and/or (3) vessel occlusion. Colour Doppler US may show the "aliasing phenomenon" post-stenosis. With full lumen occlusion, no colour signal will be detected. Whilst LVV is very rare in paediatric rheumatology, left undiagnosed or mismanaged LVV may result in serious adverse outcomes. Children and adolescents with an oncological disease and their families on the pediatric oncology ward. The perspective of those affected on the support provided by the nursing setting. It is expected that further training orientied towards a target group can improve patient care.

Approximately 2000 children and adolescents are newly diagnosed with one of about 20 types of cancer every year-they are not small adults and need special care tailored to their age and development, especially with regard to family orientation (cancer registry, GPOH, childhood cancer information). The intensive treatment strategies require close cooperation of the whole team, which has adapted to the special needs of children and adolescents (Zernikow 2008). Aim: According to R. Woodgate (2000), the opinions of affected children and adolescents are given too little attention in research studies. The needs of children, adolescents and their families in such a nursing setting are to be researched in this work. The results aim to develop a concept recommendation for further oncological nursing training Based on the theory of family oriented care (Friedemann 1995) and the principle of double action (Oevermann 1986) that is oriented towards the actual needs of children/young people and families. Questions: What forms of support are discussed from the perspective of children and adolescents with an oncological disease and their families/ parents in the context of the nursing setting in an oncological ward of a children's hospital? What is the need? Methods: 1. (Integrative) Review (Whittemore &Knafl 2005). The Search included the following databases: CINAHL, Pubmed, ZbMed, paediatric oncology institutions/working groups 2. A qualitative research design is to be applied. In order to achieve the most realistic possible representation of the social interactions and situations of action between the different Stakeholders the methodological approach of triangulation will be used. In addition to expert interviews with children and adolescents suffering from cancer, participant observation are conducted.